b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="jbb" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1940056/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>DNA Vaccines against Protozoan Parasites:\nAdvances and Challenges</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940056/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Biomedicine and Biotechnology" /><meta name="citation_title" content="DNA Vaccines against Protozoan Parasites:&#10;Advances and Challenges" /><meta name="citation_authors" content="Eric Dumonteil" /><meta name="citation_date" content="2007" /><meta name="citation_volume" content="2007" /><meta name="citation_doi" content="10.1155/2007/90520" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1940056/?report=abstract" /><meta name="citation_pmid" content="17710244" /><meta name="DC.Title" content="DNA Vaccines against Protozoan Parasites:&#10;Advances and Challenges" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Hindawi Limited" /><meta name="DC.Contributor" content="Eric Dumonteil" /><meta name="DC.Date" content="2007" /><meta name="DC.Identifier" content="10.1155/2007/90520" /><meta name="DC.Language" content="en" /><meta property="og:title" content="DNA Vaccines against Protozoan Parasites:&#10;Advances and Challenges" /><meta property="og:type" content="article" /><meta property="og:description" content="Over the past 15 years, DNA vaccines have gone from a scientific curiosity to one of the most dynamic research field and may offer new alternatives for the control of parasitic diseases such as leishmaniasis and Chagas disease. We review here some of ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940056/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jbb.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1940056/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1940056/pdf/JBB2007-90520.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1AD0C4E99ACEA10000000001DB01DA.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/94/">J Biomed Biotechnol</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/141968/">v.2007; 2007</a></li><li class="accid">PMC1940056</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jbb.gif" alt="Logo of jbb" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,500,57" alt="Journal\'s Home" title="Journal\'s Home" href="http://www.hindawi.com/journals/jbb/" ref="reftype=publisher&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="370,58,500,75" alt="Manuscript Submission" title="Manuscript Submission" href="http://mts.hindawi.com" ref="reftype=publisher&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="264,58,369,75" alt="Aims and Scope" title="Aims and Scope" href="http://www.hindawi.com/journals/jbb/aims.html" ref="reftype=publisher&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="148,58,263,75" alt="Author Guidelines" title="Author Guidelines" href="http://www.hindawi.com/journals/jbb/guidelines.html" ref="reftype=publisher&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="49,58,147,75" alt="Editorial Board" title="Editorial Board" href="http://www.hindawi.com/journals/jbb/editors.html" ref="reftype=publisher&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,58,48,75" alt="Home" title="Home" href="http://www.hindawi.com/journals/jbb/" ref="reftype=publisher&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">J Biomed Biotechnol</span>. 2007; 2007: 90520. </span></div><div><span class="fm-vol-iss-date">Published online 2007 Jun 24. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1155%2F2007%2F90520" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1155/2007/90520</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1940056</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/17710244">17710244</a></div></div></div></div><h1 class="content-title">DNA Vaccines against Protozoan Parasites:\nAdvances and Challenges</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Dumonteil%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17710244" class="affpopup" co-rid="_co_idm139846264723664" co-class="co-affbox">Eric Dumonteil</a><sup></sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139846264723664"><h3 class="no_margin">Eric Dumonteil</h3><p>Laboratorio de Parasitolog&#x000ed;a, Centro de Investigaciones Regionales &#x0201c;Dr. Hideyo Noguchi&#x0201d;, Universidad Aut&#x000f3;noma de Yucat&#x000e1;n, 97000 M&#x000e9;rida, Yucat&#x000e1;n, Mexico</p><div>Find articles by <a href="/pubmed/?term=Dumonteil%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17710244">Eric Dumonteil</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139846339904416_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139846339904416_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139846339904416_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139846339904416_ai" style="display:none"><div class="fm-affl" lang="en" id="a1">Laboratorio de Parasitolog&#x000ed;a, Centro de Investigaciones Regionales &#x0201c;Dr. Hideyo Noguchi&#x0201d;, Universidad Aut&#x000f3;noma de Yucat&#x000e1;n, 97000 M&#x000e9;rida, Yucat&#x000e1;n, Mexico</div><div id="cor1">*Eric Dumonteil: <a href="mailto:dev@null" data-email="xm.ydau@revilo" class="oemail">xm.ydau@revilo</a></div><div id="idm139846264720352">Recommended by Ali Ouaissi</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139846339904416_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2006 Dec 8; Accepted 2007 Mar 21.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139846339904416_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2007 Eric Dumonteil.</div><div class="license half_rhythm"><p id="__p2">This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1940056/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139846262986144" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139846262986144title">Abstract</h2><!--article-meta--><div><p id="__p3" class="p p-first-last">Over the past 15 years, DNA vaccines have gone from a scientific curiosity to one of the most dynamic research field and may offer new alternatives for the control of parasitic diseases such as leishmaniasis and Chagas disease. We review here some of the advances and challenges for the development of DNA vaccines against these diseases. Many studies have validated the concept of using DNA vaccines for both protection and therapy against these protozoan parasites in a variety of mouse models. The challenge now is to translate what has been achieved in these models into veterinary or human vaccines of comparable efficacy. Also, genome-mining and new antigen discovery strategies may provide new tools for a more rational search of novel vaccine candidates.</p></div></div><div id="sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1title">1. INTRODUCTION</h2><p id="__p4" class="p p-first-last">In spite of the success of vaccines in public health, there are\nstill numerous pathogens, and in particular protozoan parasites\nsuch as <em>Plasmodium falciparum, Trypanosoma</em>  sp., or\n<em>Leishmania</em> sp. against which there are still no effective vaccine.\nHowever, the discovery that the direct injection of plasmid\nDNA encoding foreign proteins could lead to endogenous\nprotein biosynthesis and a specific immune response\nagainst it opened new perspectives in vaccine development.\nOver 15 years later, DNA vaccines have gone from a scientific\ncuriosity to one of the most dynamic fields of research\nand may offer new alternatives for the control of infectious\ndiseases [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124471">1</a>]. Indeed, the first two DNA vaccines have been licenced,\nin recent years, to protect horses from west nile virus\nand salmons from infectious hematopoietic necrosis virus,\nconfirming the usefulness of this biotechnology. We review\nhere some of the advances and challenges for the development\nof DNA vaccines against two well-studied protozoan\nparasites, <em>Leishmania</em> sp. and <em>Trypanosoma cruzi</em>. Both belong\nto the trypanosomatidae family and are ranked among\nthe three major protozoan parasites affecting humans. Leishmaniasis\nis a complex disease caused by at least 18 species\nof parasites from the <em>Leishmania</em> genus and transmitted to\nhumans by hematophagous sandflies. With an estimated 12\nmillion cases, it has a major public health impact in several\nregions, and in particular in India, Sudan, and Brazil [<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311658050">2</a>].\nClinical manifestations range from self-healing cutaneous lesion\nto fatal visceral form, and this variety can be attributed\nin part to the respective parasite species, and each presents\nspecific relationships with the host and diverse mechanisms\nof pathogenesis [<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124477">3</a>, <a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124501">4</a>], which represents an additional difficulty\nfor the development of treatments and vaccines. On the\nother hand, <em>T. cruzi</em> is the agent of Chagas disease, which is\npresent from southern Argentina to the southern USA. An\nestimated 16&#x02013;18 million persons are infected in the Americas\nand close to 100 million people are at risk of infection.\nAfter a short benign acute phase (a few weeks) and a very\nlong (several years) asymtomatic phase, about 30&#x02013;40% of infected\npatients develop chronic chagasic cardiomyopathy and\neventualy die of heart failure. Current chemotherapy relies\non nitrofurans (Nifurtimox), or nitroimidazoles (Benznidazole).\nHowever, the usefulness of these drugs is limited by\ntheir reduced efficacy (mostly during the early stages of the\ninfection), serious side effects, and the emergence of drugresistant\nstrains of parasites, and new treatments are slow to\ndevelop [<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124454">5</a>].</p></div><div id="sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2title">2. WHY DNA VACCINES?</h2><p id="__p5" class="p p-first-last">DNA vaccines induce a complete immune response against\nthe encoded antigen. The exact mechanisms involved in this\nproccess are still poorly understood, and particularly the type\nof CD4<sup>+</sup> and CD8<sup>+</sup> effector and memory cells activated, and some of these aspects have been reviewed in detail elsewhere\n[<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124491">1</a>]. Apart from their immunogenicity and efficacy that will\nbe discussed below, there are several features of DNA vaccines\nthat make them very advantageous against tropical diseases.\nFirst, they are extremely safe as they do not contain any\npathogenic organism that may revert in virulence. The major\nconcern of genomic integration of the plasmid DNA has\nalso extensively been studied in safety studies and found to\nbe rather unlikely [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124514">6</a>]. Additional safety issues such as anti-DNA antibodies or autoimmunity have also been addressed\nin a growing number of preclinical and clinical studies [<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124458">7</a>],\nwhich confirmed the high safety of these vaccines. With respect\nto manufacturing, storage, and distribution, they also\npresent major benefits in that the production process is the\nsame for any DNA vaccine, which is not the case for other\ntypes of biologicals and vaccines, for which a specific protocol\nhas to be developed for each. This makes production easy\nand costs will likely go down as this type of vaccines become\nmainstream and future technological improvements are implemented.\nAlso, plasmid DNA is a very stable molecule,\nspecially compared to recombinant or live attenuated vaccines,\nwhich would greatly facilitate storage and distribution\nof DNA vaccine in tropical settings with limited health infrastructure\nas the huge costs associated with the cold chain\nmay be offset. Administration is also easy as simple IM or\nID injections can be sufficient, and multiple plasmids can\nbe combined for the elaboration of multivalent vaccines [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124503">1</a>].\nOverall, DNA vaccines may thus represent an ideally affordable\nalternative for disease control, which explains in part the\ngrowing interest in their development for the control of tropical\nparasitic diseases such as malaria, Leishmaniasis, or Chagas\ndisease.</p></div><div id="sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3title">3. DNA VACCINES AGAINST LEISHMANIA</h2><div id="subsec3.1" class="sec sec-first"><h3 id="subsec3.1title">3.1. Correlates for protection</h3><p id="__p6" class="p p-first">As mentioned above, leishmaniasis is caused by at least\n18 species of parasites with diverse relationships with the\nhost and mechanisms of pathogenesis [<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124527">3</a>, <a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124442">4</a>]. Early studies\nof cross-protection between <em>Leishmania</em> species clearly\nshowed that it is a complex problem, with infection by one\nspecies protecting or not from subsequent infection by another\nspecies, depending on the species and the order of infections.\nMost vaccine studies have thus been focusing on homologous\nprotection, although a single vaccine able to protect\nagainst all pathogenic species would be ideal.</p><p id="__p7" class="p p-last">The correlates for protection have been extensively studied\nin the case of <em>L. major</em>, and contributed considerably to\nthe development of the Th1/Th2 paradigm [<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124472">8</a>]. Thus, there\nis a general agreement that a Th1-type immune response,\ncharacterized by a high IFN<em>&#x003b3;</em> and low IL-4 and IL-10 production,\nleads to control of <em>L. major</em> infection, while a Th2-type immune response does not [<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124462">8</a>]. Antibodies may have\nan exacerbatory role [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124468">9</a>], but may also contribute to T cell\nresponses [<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124508">10</a>, <a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124510">11</a>]. Both IFN<em>&#x003b3;</em> producing CD4<sup>+</sup> and CD8<sup>+</sup>T\ncells seem to contribute to protective immunity, and induction\nof NO production by macrophages is central to parasite\nelimiation [<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124446">12</a>, <a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124519">13</a>]. While it was assumed for a long time that\nthis Th1/Th2 paradigm was applied to all <em>Leishmania</em> species,\nit has become clear in recent years that each species has a\ndistinct relationship with the host, different mechanisms of\npathogenesis, and possibly different correlates for protection\n[<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124445">3</a>, <a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124457">4</a>]. Nonetheless, IFN<em>&#x003b3;</em> production seems to be a general\nrequirement, although not necessarily sufficient, for protection\nagainst most if not all <em>Leishmania</em> species.</p></div><div id="subsec3.2" class="sec"><h3 id="subsec3.2title">3.2. Single antigen DNA vaccines</h3><p id="__p8" class="p p-first">The earliest DNA vaccine experiments against <em>Leishmania</em>\nused <em>L. major</em> GP63 antigen, which has been extensively used\nas a recombinant or peptide vaccine. Immunization with a\nplasmid encoding GP63 was able to induce a Th1-type cytokine\nprofile and a significant reduction of lesion size after\nchallenge of the immunized mice with <em>L. major</em> [<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124438">14</a>&#x02013;<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124449">17</a>]. Subsequent\nstudies investigated DNA vaccines encoding a large\nvariety of <em>Leishmania</em> proteins (<a href="/pmc/articles/PMC1940056/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>) and showed that\nmany different DNA vaccines were able to induce a Th1 immune\nresponse, and confer variable degrees of protection as\nassessed by reduction in skin lesion size and/or parasite burdens\nin mouse models. However, given the large variety in experimental\nmodels and designs, it is difficult to compare the\neffectiveness of the different vaccines to induce a protective\nimmune response. Nonetheless, it is clear from studies comparing\ndifferent DNA vaccines that the nature of the antigen\nencoded by the vaccine is a key parameter for efficacy.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p30">DNA vaccines tested against murine leishmaniasis.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139846270944176" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody><tr><td rowspan="1" colspan="1">Antigen</td><td align="center" rowspan="1" colspan="1">Dose</td><td align="center" rowspan="1" colspan="1">Challenge</td><td align="center" rowspan="1" colspan="1">Immune response</td><td align="center" rowspan="1" colspan="1">Protection</td><td align="center" rowspan="1" colspan="1">Reference</td></tr><tr><td colspan="6" rowspan="1"><hr /></td></tr><tr><td rowspan="1" colspan="1">GP63</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B14" rid="B14" class=" bibr popnode">14</a>&#x02013;<a href="#B17" rid="B17" class=" bibr popnode">17</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1, IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B18" rid="B18" class=" bibr popnode">18</a>&#x02013;<a href="#B21" rid="B21" class=" bibr popnode">21</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 30 <em>&#x003bc;</em>g IN</td><td align="center" rowspan="1" colspan="1"><em>L. amazonensis</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B22" rid="B22" class=" bibr popnode">22</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. mexicana</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">[<a href="#B23" rid="B23" class=" bibr popnode">23</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM or SC</td><td align="center" rowspan="1" colspan="1"><em>L. chagasi</em></td><td align="center" rowspan="1" colspan="1">Th1, IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">[<a href="#B24" rid="B24" class=" bibr popnode">24</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g ID or SC</td><td align="center" rowspan="1" colspan="1"><em>L. chagasi</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">[<a href="#B25" rid="B25" class=" bibr popnode">25</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">Prime/boost</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B26" rid="B26" class=" bibr popnode">26</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">Prime/boost</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B27" rid="B27" class=" bibr popnode">27</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">Prime/boost</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1, IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B28" rid="B28" class=" bibr popnode">28</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">Prime/boost</td><td align="center" rowspan="1" colspan="1"><em>L. infantum</em></td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B29" rid="B29" class=" bibr popnode">29</a>]</td></tr><tr><td rowspan="1" colspan="1">TRYP</td><td align="center" rowspan="1" colspan="1">Prime/boost</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B30" rid="B30" class=" bibr popnode">30</a>]</td></tr><tr><td rowspan="1" colspan="1">LiP0</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g im</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">++</td><td align="center" rowspan="1" colspan="1">[<a href="#B31" rid="B31" class=" bibr popnode">31</a>]</td></tr><tr><td rowspan="1" colspan="1">SP1</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g SC or prime/boost</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">++</td><td align="center" rowspan="1" colspan="1">[<a href="#B32" rid="B32" class=" bibr popnode">32</a>]</td></tr><tr><td rowspan="1" colspan="1">Histones mix: H2A, H2B,\nH3, H4</td><td align="center" rowspan="1" colspan="1">3 &#x000d7; 200 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1, IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B22" rid="B22" class=" bibr popnode">22</a>]</td></tr><tr><td rowspan="1" colspan="1">LmSTI1, TSA</td><td align="center" rowspan="1" colspan="1">3 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B33" rid="B33" class=" bibr popnode">33</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK, LmSTI1, TSA</td><td align="center" rowspan="1" colspan="1">1 &#x000d7; 300 <em>&#x003bc;</em>g SC</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B13" rid="B13" class=" bibr popnode">13</a>]</td></tr><tr><td rowspan="1" colspan="1">CPb/CPa</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B34" rid="B34" class=" bibr popnode">34</a>]</td></tr><tr><td rowspan="1" colspan="1">PSA-2</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 20&#x02013;50 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B35" rid="B35" class=" bibr popnode">35</a>]</td></tr><tr><td rowspan="1" colspan="1">LACK, PSA2, Gp63, LeIF,\np20 Ribosomal like protein</td><td align="center" rowspan="1" colspan="1">1 &#x000d7; 50 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">&#x02212; to +++</td><td align="center" rowspan="1" colspan="1">[<a href="#B36" rid="B36" class=" bibr popnode">36</a>]</td></tr><tr><td rowspan="1" colspan="1">Meta 1</td><td align="center" rowspan="1" colspan="1">3 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. major</em></td><td align="center" rowspan="1" colspan="1">Th2</td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">[<a href="#B37" rid="B37" class=" bibr popnode">37</a>]</td></tr><tr><td rowspan="1" colspan="1">P4</td><td align="center" rowspan="1" colspan="1">3 &#x000d7; 100 <em>&#x003bc;</em>g various sites</td><td align="center" rowspan="1" colspan="1"><em>L. amazonensis</em></td><td align="center" rowspan="1" colspan="1">Th1</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B38" rid="B38" class=" bibr popnode">38</a>]</td></tr><tr><td rowspan="1" colspan="1">CPb, GP63, GP46</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. mexicana</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">+ to +++</td><td align="center" rowspan="1" colspan="1">[<a href="#B23" rid="B23" class=" bibr popnode">23</a>, <a href="#B39" rid="B39" class=" bibr popnode">39</a>]</td></tr><tr><td rowspan="1" colspan="1">NH36</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. domovani</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B40" rid="B40" class=" bibr popnode">40</a>]</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><em>L. mexicana</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">++</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">NH36, GP63</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 20 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. mexicana</em></td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B41" rid="B41" class=" bibr popnode">41</a>]</td></tr><tr><td rowspan="1" colspan="1">CPa/CPb</td><td align="center" rowspan="1" colspan="1">Prime/Boost</td><td align="center" rowspan="1" colspan="1"><em>L. infantum</em></td><td align="center" rowspan="1" colspan="1">Th1, IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B42" rid="B42" class=" bibr popnode">42</a>]</td></tr><tr><td rowspan="1" colspan="1">ORFF</td><td align="center" rowspan="1" colspan="1">3 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. donovani</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B43" rid="B43" class=" bibr popnode">43</a>]</td></tr></tbody></table></div><div id="largeobj_idm139846270944176" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1940056/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF1"><p id="__p31" class="p p-first-last">IM: intramuscular; IN: intranasal; SC: subcutaneous; &#x02212;: no protection; +: little protection; ++: fair protection; +++: very good protection.</p></div></div></div><p id="__p9">Also, a few studies provided interesting comparisons of\nthe same antigens administered as recombinant protein or\nDNA vaccines and showed that the latter were overall more\neffective than their recombinant protein counterparts. Indeed,\nDNA vaccines were able to induce a stronger Th1 bias\nin the immune response, a longer-lasting immunity, and/or a\nbetter protection against disease progression [<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124533">19</a>, <a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124482">31</a>, <a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124423">32</a>, <a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124466">35</a>, <a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124447">40</a>, <a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124444">44</a>]. While most of these studies have used a rather artificial\ninfectious challenge based on the injection via nonnatural\nroutes of high parasite doses, an experimental system criticized\nby some authors, the superior efficacy of DNA vaccines\nwas also observed using a low-dose intradermal challenge in\nthe ear, which was proposed to more closely mimick natural\ninfection [<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124429">45</a>]. In these studies, both DNA and protein vaccination\nwere able to induce very similar level of short-term (2\nweeks postvaccination) protection against infection with <em>L. major</em>, but only DNA vaccine was able to induce long-term\n(12 weeks postvaccination) protection [<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124526">45</a>].</p><p id="__p10" class="p p-last">These results thus confirmed the strong potential of DNA\nvaccines against <em>Leishmania</em>, but also indicated that in most\ncases only partial protection was achieved. Prime-boost immunization\nprotocols have been tested with various antigens\nto increase vaccine potency (<a href="/pmc/articles/PMC1940056/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). They are based\non priming the immune response with a DNA vaccine and\nboosting with the corresponding recombinant vaccine based\non recombinant virus or protein (<a href="/pmc/articles/PMC1940056/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). In some studies,\nsuch immunization protocol resulted in increased immunogenicity\nof the vaccines and better protection levels [<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124497">26</a>, <a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124507">27</a>],\nbut in others, DNA only remained the best formulation for\noptimum efficacy [<a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124505">32</a>]. Nonetheless, a major drawback of such vaccine formulation remains its complexity, which may\nlimit their practical use.</p></div><div id="subsec3.3" class="sec"><h3 id="subsec3.3title">3.3. Multiple antigen DNA vaccines</h3><p id="__p11" class="p p-first-last">An alternative way to broaden vaccine immunogenicity and\nincrease its efficacy has been to use combination of plasmids\nencoding various antigens. For examples, cysteine proteinase\n(CP) a and b DNA vaccines are not protective when\nused individually, but immunization with a combination of\nboth plasmids induces long-term protective immunity [<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124540">34</a>].\nAlternatively, gene fusion has also been successively used to\nachieve expression of an antigenic fusion protein from a single\nplasmid construct [<a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124532">33</a>]. Overall, expression of several\nantigens mostly resulted in increased efficacy, but this also\ndepended on the antigen combination [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124504">13</a>, <a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124500">22</a>, <a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124489">23</a>, <a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124512">41</a>, <a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124536">45</a>].\nMost authors thus argue that a successful <em>Leishmania</em> vaccine\nis likely to be based on multiple antigens.</p></div><div id="subsec3.4" class="sec"><h3 id="subsec3.4title">3.4. Antigen discovery</h3><p id="__p12" class="p p-first-last">Immunization with large number of plasmids is also the basis\nfor expression library immunization, a powerful but labor intensive\nstrategy for vaccine discovery [<a href="#B46" rid="B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124485">46</a>], which has been\nused with <em>Leishmania</em>. Immunization of mice with <em>L. major</em>\ngenomic expression library fractions was able to induce\nsignificant protection, but these authors did not pursue library\nfractionation further [<a href="#B47" rid="B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124436">47</a>]. In another study, the identification\nof protective library subsets from an <em>L. donovani</em>\namastigote cDNA library and their successive fractionation\ninto smaller protective libraries lead to the identification of\nnovel protective antigens [<a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124428">48</a>]. Interestingly, most of the antigens\nidentified would not have been predicted to be good vaccine candidates. Indeed, they were not surface or secreted\nproteins, neither stage-specific, but were intracellular and\nsome very conserved such as histones, or ribosomal proteins\n[<a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124513">48</a>]. Vaccine discovery is also the next logical step following\nthe recent completion of the <em>L. major</em> genome sequencing\n[<a href="#B49" rid="B49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124478">49</a>]. In one approach, the random screening of 100 genes\nupregulated in amastigotes tested as DNA vaccine allowed\nthe identification of 14 novel protective and 7 exacerbating\nantigens [<a href="#B50" rid="B50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124473">50</a>, <a href="#B51" rid="B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124484">51</a>]. Again, function and cellular localization\nwould have been poor predictors of the protective efficacy\nof these antigens, as most were not predicted to be localized\non the surface, but shared similarity with ribosomal proteins,\ncytoskeleton, or metabolic enzymes [<a href="#B51" rid="B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124487">51</a>]. It is thus becoming\nincreasingly clear that there is little rationale to limit <em>Leishmania</em>\nvaccine discovery searches to surface or secreted antigens.\nRather, new criteria need to be considered for the rational\nidentification of vaccine candidates as strategies based on\nsuch random screening cannot be applied to large genomes\nsuch as that of <em>Leishmania</em>, with over 8000 annotated genes.</p></div><div id="subsec3.5" class="sec"><h3 id="subsec3.5title">3.5. Therapeutic vaccines</h3><p id="__p13" class="p p-first-last">An additional advantage of DNA vaccines is their potential\nas therapeutic vaccines, aimed at reinforcing or redirecting\nthe immune response of an infected host to control disease\nprogression [<a href="#B58" rid="B58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124483">58</a>]. The major advantage of this strategy in addition\nto its efficacy is that it relies on short treatment regimens,\nand it is thus an attractive alternative to chemotherapy,\nparticularly in the case of <em>Leishmania</em> with so few chemotherapeutic\noptions. Thus, administration of as little as two doses\nof a DNA vaccine encoding PSA-2 can control an ongoing infection\nwith <em>L. major</em> in mice [<a href="#B59" rid="B59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124427">59</a>]. The therapeutic effect is\ndue to a shift of the immune response towards a Th1 immune\nresponse [<a href="#B59" rid="B59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124453">59</a>]. Similarly, a DNA vaccine encoding <em>L.\ndonovani</em> nucleoside hydrolase NH36 has therapeutic activity\nagainst murine visceral leishmaniasis caused by <em>L. chagasi</em>\n[<a href="#B60" rid="B60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124437">60</a>]. The simplicity of such treatment makes them very advantageous\ncompared to chemotherapy. In addition, the fact\nthat the same DNA vaccine can be effective for both the prophylaxis\n[<a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124443">40</a>] and the therapy of <em>Leishmania</em> infection is thus\nvery promising as this would provide a versatile tool for the\ncontrol of this parasite.</p></div><div id="subsec3.6" class="sec"><h3 id="subsec3.6title">3.6. Cross-protection against multiple\nLeishmania species</h3><p id="__p14" class="p p-first-last">As mentioned above, an added challenge to <em>Leishmania</em> vaccine\ndevelopment is the large number of species, as well as\nthe variability within species. Indeed, studies on the polymorphism\nof leading antigens such as GP63 quickly revealed\nthat it was a very polymorphic [<a href="#B61" rid="B61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124430">61</a>, <a href="#B62" rid="B62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124538">62</a>]. Such polymorphism\nhas important implication for vaccine development as it may\nlimit their efficacy against variant strains of parasites or novel\nescape mutants, and thus restrict vaccine protection to a single\nspecies [<a href="#B63" rid="B63" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124460">63</a>, <a href="#B64" rid="B64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124432">64</a>]. Antigen polymorphism between multiple\nstrains and species is thus becoming a major issue in\nmany vaccine development studies [<a href="#B65" rid="B65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124450">65</a>, <a href="#B66" rid="B66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124516">66</a>]. In the case of\n<em>Leishmania</em>, few DNA vaccines have been tested against multiple\nspecies. LACK antigen, initially identified in <em>L. major</em>,\nand found to be very conserved between <em>Leishmania</em> species,\ncan protect mice against <em>L. major</em> [<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124451">20</a>] and \n<em>L. amazonensis</em>\n[<a href="#B67" rid="B67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124486">67</a>], but not against <em>L. mexicana</em> [<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124492">23</a>], <em>L. donovani</em> [<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124530">25</a>], or\n<em>L. chagasi</em> [<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124506">24</a>]. On the other hand, <em>L. amazonensis</em> nuclease\nprotein P4 can protect against both <em>L. amazonensis</em> and\n<em>L. major</em>, but cross-protection requires a different formulation\n(IL-12 or HSP70 as adjuvant, resp.) [<a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124498">38</a>]. In other studies,\nantigens from one species were used to induce protection\nagainst another species [<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124495">31</a>], but the extent of cross-protection\nagainst various species was not investigated. More\nrecently, a single formulation of <em>L. donovani</em> NH36 DNA vaccine\nwas found to induce a very good protection against both\n<em>L. chagasi</em> and <em>L. mexicana</em>, suggesting that this DNA vaccine\nmay be able to provide broad protection against various\n<em>Leishmania</em> species [<a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124461">40</a>]. Importantly, no DNA vaccine has\nyet been tested against <em>L. braziliensis</em>, in spite of this species\nbeing responsible of most cases of cutaneous leishmaniasis in\nSouth America.</p></div><div id="subsec3.7" class="sec"><h3 id="subsec3.7title">3.7. Non-Leishmania antigens as vaccines</h3><p id="__p15" class="p p-first-last">While all the above DNA vaccines were based on <em>Leishmania</em>\nantigens, an alternative approach has used antigens derived\nfrom sand-fly saliva. Indeed, it has been shown that sand-fly\nsaliva can exacerbate <em>Leishmania</em> infection [<a href="#B68" rid="B68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124481">68</a>, <a href="#B69" rid="B69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124523">69</a>], and preexposure\nof mice to saliva components may be sufficient to\ninduce protection against infection [<a href="#B70" rid="B70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124470">70</a>]. Thus, a number of\nsalivary antigens have been tested as vaccines against <em>Leishmania</em>.\nMaxadilan is a potent vasodilator from sand-fly saliva\nand was found to be responsible of most of the exacerbatory\neffects of whole saliva on <em>Leishmania</em> infection [<a href="#B71" rid="B71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124499">71</a>]. Immunization\nwith this antigen (as a recombinant vaccine) protected\nmice against <em>L. major</em> infection [<a href="#B71" rid="B71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124469">71</a>]. Other salivary\ncomponents, such as <em>Phlebotomus papatasi</em> SP15, have been\ntested as DNA vaccines and found to protect mice against\n<em>L. major</em> and while the vaccine induced both humoral and\nDTH responses, protection seemed to be mostly accounted\nfor by the latter, as B-cell deficient mice remain protected\n[<a href="#B72" rid="B72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124448">72</a>]. Thus, characterization of sand-fly salivary proteins may\nlead to the identification of new vaccine candidates [<a href="#B73" rid="B73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124509">73</a>, <a href="#B74" rid="B74" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124535">74</a>].\nHowever, as for <em>Leishmania</em> antigens, salivary protein polymorphism\nremains an important issue and may limit the usefulness\nof such antigens as vaccine candidates [<a href="#B75" rid="B75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124502">75</a>, <a href="#B76" rid="B76" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124431">76</a>].</p></div><div id="subsec3.8" class="sec sec-last"><h3 id="subsec3.8title">3.8. DNA vaccines against nonmurine leishmaniasis</h3><p id="__p16" class="p p-first-last">Based on the success of many of these DNA vaccine studies\nin mice, a few vaccine candidates have been tested in additional\nanimal models, possibly more relevants for the development\nof a veterinary or human vaccine (<a href="/pmc/articles/PMC1940056/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). PFR-2\nand KMP11 antigens were tested as DNA vaccines in hamsters,\na highly susceptible animal model. PFR-2 was tested as\nprotein, DNA, or DNA-protein immunization, and protection\nlevels against <em>L. mexicana</em> varied greatly depending on\nvaccine formulation, route of immunization, and sex of the\nanimals [<a href="#B52" rid="B52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124463">52</a>]. Also, contrary to mouse studies, protein vaccination\nseemed more protective than DNA only vaccination. However, as in mouse studies, heterologous prime-boost\nvaccination with DNA and protein seemed better than DNA\nonly [<a href="#B52" rid="B52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124459">52</a>]. Another DNA vaccine encoding PapLe22 was\nfound to be immunogenic in hamsters and decreased parasitemia\nafter infection with <em>L. infantum</em>, but further assessment\nof disease was not performed [<a href="#B54" rid="B54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124439">54</a>]. Immunization with\nKPM11 DNA induced a mixed Th1/Th2 response, but was\nable to protect hamsters against visceral leishmaniasis caused\nby <em>L. donovani</em>  [<a href="#B53" rid="B53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124521">53</a>]. In dogs, while several protein vaccines\nhave been tested and a purified protein vaccine has now been\nlicenced for veterinary use [<a href="#B77" rid="B77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124424">77</a>], very few DNA vaccine studies\nhave been performed. A heterologous prime-boost strategy\nusing CPa and CPb DNA and protein was reported as\nimmunogenic and protective [<a href="#B57" rid="B57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124534">57</a>], but the study was of limited\npower given the reduced number of animals. In another\nstudy, dogs were immunized with a mixture of DNA vaccines\nencoding 10 different antigens previously tested in mouse\nmodels, and this immunization induced a very good immune\nresponse, with a high production of IFN<em>&#x003b3;</em> [<a href="#B56" rid="B56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124475">56</a>]. However,\nevaluation of protection was limited to an acute <em>in vitro</em> assay\n[<a href="#B56" rid="B56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124488">56</a>] and further studies will be required to assess the potential\nof this vaccine in dogs. In spite of their limitations, these\nstudies clearly showed that several DNA vaccines can induce\na potent immune response in nonmurine animal models,\nand it is likely that a good level of protection can be achieved\nin these as well, provided the correct antigens and vaccine\nformulation are used.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p32">Preclinical studies <em>Leishmania</em> DNA vaccines in nonmurine models.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139846271298352" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody><tr><td rowspan="1" colspan="1">Antigen</td><td align="center" rowspan="1" colspan="1">Dose</td><td align="center" rowspan="1" colspan="1">Challenge</td><td align="center" rowspan="1" colspan="1">Host</td><td align="center" rowspan="1" colspan="1">Immune response</td><td align="center" rowspan="1" colspan="1">Protection</td><td align="center" rowspan="1" colspan="1">Reference</td></tr><tr><td colspan="7" rowspan="1"><hr /></td></tr><tr><td rowspan="1" colspan="1">PFR-2</td><td align="center" rowspan="1" colspan="1">Variable</td><td align="center" rowspan="1" colspan="1"><em>L. mexicana</em></td><td align="center" rowspan="1" colspan="1">Hamster</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">&#x02212; to +++</td><td align="center" rowspan="1" colspan="1">[<a href="#B52" rid="B52" class=" bibr popnode">52</a>]</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><em>L. panamensis</em></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">KMP11</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. donovani</em></td><td align="center" rowspan="1" colspan="1">Hamster</td><td align="center" rowspan="1" colspan="1">Th1-Th2</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B53" rid="B53" class=" bibr popnode">53</a>]</td></tr><tr><td rowspan="1" colspan="1">PapLe22</td><td align="center" rowspan="1" colspan="1">1 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. infantum</em></td><td align="center" rowspan="1" colspan="1">Hamster</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B54" rid="B54" class=" bibr popnode">54</a>]</td><td rowspan="1" colspan="1"></td></tr><tr><td colspan="7" rowspan="1"><hr /></td></tr><tr><td rowspan="1" colspan="1">LACK</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM or Prime/boost</td><td align="center" rowspan="1" colspan="1"><em>L. infantum</em></td><td align="center" rowspan="1" colspan="1">Dog</td><td align="center" rowspan="1" colspan="1">Th1/Th2 Th1</td><td align="center" rowspan="1" colspan="1">+ to +++</td><td align="center" rowspan="1" colspan="1">[<a href="#B55" rid="B55" class=" bibr popnode">55</a>]</td></tr><tr><td rowspan="1" colspan="1">10 antigens mix</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 500 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1"><em>L. donovani</em></td><td align="center" rowspan="1" colspan="1">Dog</td><td align="center" rowspan="1" colspan="1">Th1</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">[<a href="#B56" rid="B56" class=" bibr popnode">56</a>]</td></tr><tr><td rowspan="1" colspan="1">CPa/b</td><td align="center" rowspan="1" colspan="1">Prime/boost</td><td align="center" rowspan="1" colspan="1"><em>L. infantum</em></td><td align="center" rowspan="1" colspan="1">Dog</td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B57" rid="B57" class=" bibr popnode">57</a>]</td></tr></tbody></table></div><div id="largeobj_idm139846271298352" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1940056/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF2"><p id="__p33" class="p p-first-last">&#x02212;: no protection; +: little protection; ++: fair protection; +++: very good protection.</p></div></div></div></div></div><div id="sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4title">4. DNA VACCINES AGAINST TRYPANOSOMA CRUZI</h2><div id="subsec4.1" class="sec sec-first"><h3 id="subsec4.1title">4.1. Correlates for protection</h3><p id="__p17" class="p p-first-last">Vaccine development against Chagas disease has been dramatically\nlimited because of extensive debate on the mechanisms\ninvolved in this pathology [<a href="#B78" rid="B78" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124515">78</a>, <a href="#B79" rid="B79" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311658049">79</a>]. Indeed, some studies\nsuggested that tissue damage was associated with the presence\nand replication of intracellular amastigotes, while others\nproposed that autoimmunity induced by parasite antigens\nmimicking host proteins was responsible for it. It was thus\nunclear if the immune response needed to be inhibited, to reduce\nautoimmunity, or stimulated, to eliminate the parasite.\nIt is now accepted that the presence of parasites in cardiac\ntissue is necessary to initiate and maintain the inflammatory\nresponse, and that therapeutic treatments or vaccines aimed\nat eliminating <em>T. cruzi</em> would limit or prevent the progression\ntowards chronic chagasic cardiomyopathy [<a href="#B80" rid="B80" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124441">80</a>, <a href="#B81" rid="B81" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124522">81</a>]. There is a\ngrowing consensus that protection against <em>T. cruzi</em> relies on a\nTh1 immune response and the activation of cytotoxic CD8<sup>+</sup>T\ncells [<a href="#B82" rid="B82" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124455">82</a>&#x02013;<a href="#B85" rid="B85" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311658048">85</a>].</p></div><div id="subsec4.2" class="sec"><h3 id="subsec4.2title">4.2. Single antigen DNA vaccines</h3><p id="__p18" class="p p-first">The first DNA vaccines to be tested against <em>T. cruzi</em> encoded\nan antigen from the well characterized trans-sialidase family\nof proteins. There are over 1400 members in this family,\nmaking it one of the largest protein families of the parasite,\nand they are very abundant surface proteins. Several\nstudies have used different members of this family, such as\nTS or TSA-1 (<a href="/pmc/articles/PMC1940056/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>) [<a href="#B84" rid="B84" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124426">84</a>, <a href="#B86" rid="B86" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124452">86</a>&#x02013;<a href="#B88" rid="B88" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124517">88</a>]. Immunization with TS\nwas found to induce significant antibody titers able to inhibit\ntrans-sialidase enzyme activity, a strong DTH, and lymphoproliferative\nresponse [<a href="#B86" rid="B86" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124496">86</a>]. This immune response was\nprotective as determined by an increase in survival and a decrease\nin parasitemia. Immunization with TSA-1 DNA was\nfound to induce a specific CTL response which also lead to a\nlower parasitemia and increased survival in both BALB/c and\nC57BL/6 mice [<a href="#B88" rid="B88" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124494">88</a>].</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p34">DNA vaccines tested against <em>Trypanosoma cruzi.</em></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139846342914016" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody><tr><td rowspan="1" colspan="1">Antigen</td><td align="center" rowspan="1" colspan="1">Type of antigen</td><td align="center" rowspan="1" colspan="1">Dose</td><td align="center" rowspan="1" colspan="1">Mouse strain</td><td align="center" rowspan="1" colspan="1">Immune response</td><td align="center" rowspan="1" colspan="1">Protection</td><td align="center" rowspan="1" colspan="1">Reference</td></tr><tr><td colspan="7" rowspan="1"><hr /></td></tr><tr><td rowspan="1" colspan="1">TS 154</td><td align="center" rowspan="1" colspan="1">TS family</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">BALB/c</td><td align="center" rowspan="1" colspan="1">Th1, CTL</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B84" rid="B84" class=" bibr popnode">84</a>, <a href="#B89" rid="B89" class=" bibr popnode">89</a>, <a href="#B90" rid="B90" class=" bibr popnode">90</a>]</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">A/Sn</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="2" colspan="1">TSA-1</td><td align="center" rowspan="2" colspan="1">TS family</td><td align="center" rowspan="2" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">C57BL/6</td><td align="center" rowspan="2" colspan="1">CTL</td><td align="center" rowspan="2" colspan="1">+++</td><td align="center" rowspan="2" colspan="1">[<a href="#B87" rid="B87" class=" bibr popnode">87</a>, <a href="#B91" rid="B91" class=" bibr popnode">91</a>]</td></tr><tr><td align="center" rowspan="1" colspan="1">BALB/c</td></tr><tr><td rowspan="1" colspan="1">ASP-1</td><td align="center" rowspan="1" colspan="1">TS family</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">C57BL/6</td><td align="center" rowspan="1" colspan="1">CTL</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B87" rid="B87" class=" bibr popnode">87</a>]</td></tr><tr><td rowspan="1" colspan="1">ASP-2</td><td align="center" rowspan="1" colspan="1">TS family</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">C57BL/6</td><td align="center" rowspan="1" colspan="1">CTL</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B87" rid="B87" class=" bibr popnode">87</a>]</td></tr><tr><td rowspan="1" colspan="1">Tc13</td><td align="center" rowspan="1" colspan="1">TS family</td><td align="center" rowspan="1" colspan="1">5 &#x000d7; 50 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">BALB/c</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">&#x02212;</td><td align="center" rowspan="1" colspan="1">[<a href="#B92" rid="B92" class=" bibr popnode">92</a>]</td></tr><tr><td rowspan="1" colspan="1">ASP-clone9</td><td align="center" rowspan="1" colspan="1">TS family</td><td align="center" rowspan="1" colspan="1">4 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">BALB/c</td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B93" rid="B93" class=" bibr popnode">93</a>]</td></tr><tr><td rowspan="3" colspan="1">TSSA</td><td align="center" rowspan="3" colspan="1">TS family</td><td align="center" rowspan="3" colspan="1">2 to 4 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">BALB/c,</td><td align="center" rowspan="3" colspan="1">CTL</td><td align="center" rowspan="3" colspan="1">&#x02212; to +++</td><td align="center" rowspan="3" colspan="1">[<a href="#B94" rid="B94" class=" bibr popnode">94</a>, <a href="#B95" rid="B95" class=" bibr popnode">95</a>]</td></tr><tr><td align="center" rowspan="1" colspan="1">C57BL/6</td></tr><tr><td align="center" rowspan="1" colspan="1">C3H/Hej</td></tr><tr><td rowspan="1" colspan="1">TS (7 members mix)</td><td align="center" rowspan="1" colspan="1">TS family</td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 25 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">C57BL/6</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B96" rid="B96" class=" bibr popnode">96</a>]</td></tr><tr><td rowspan="1" colspan="1">ASP-clone9, TS</td><td align="center" rowspan="1" colspan="1">TS family</td><td align="center" rowspan="1" colspan="1">4 &#x000d7; 200 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">BALB/c</td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B97" rid="B97" class=" bibr popnode">97</a>]</td></tr><tr><td rowspan="1" colspan="1">CRP</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">BALB/c</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B98" rid="B98" class=" bibr popnode">98</a>]</td></tr><tr><td rowspan="1" colspan="1">cruzipain</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">BALB/c</td><td align="center" rowspan="1" colspan="1">CTL</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">[<a href="#B99" rid="B99" class=" bibr popnode">99</a>]</td></tr><tr><td rowspan="3" colspan="1">DHOD</td><td rowspan="3" colspan="1"></td><td align="center" rowspan="3" colspan="1">2 to 4 &#x000d7; 100 <em>&#x003bc;</em>g IM</td><td align="center" rowspan="1" colspan="1">BALB/c,</td><td rowspan="3" colspan="1"></td><td align="center" rowspan="3" colspan="1">&#x02212;</td><td align="center" rowspan="3" colspan="1">[<a href="#B94" rid="B94" class=" bibr popnode">94</a>]</td></tr><tr><td align="center" rowspan="1" colspan="1">C57BL/6</td></tr><tr><td align="center" rowspan="1" colspan="1">C3H/Hej</td></tr><tr><td rowspan="1" colspan="1">LYT1</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 25 <em>&#x003bc;</em>g</td><td align="center" rowspan="1" colspan="1">C57BL/6</td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em>, CTL</td><td align="center" rowspan="1" colspan="1">+++</td><td align="center" rowspan="1" colspan="1">[<a href="#B96" rid="B96" class=" bibr popnode">96</a>]</td></tr><tr><td rowspan="1" colspan="1">FCaBP/Tc24</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 25 <em>&#x003bc;</em>g</td><td align="center" rowspan="1" colspan="1">C57BL/6</td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em>, CTL</td><td align="center" rowspan="1" colspan="1">&#x02012;</td><td align="center" rowspan="1" colspan="1">[<a href="#B96" rid="B96" class=" bibr popnode">96</a>]</td></tr><tr><td rowspan="1" colspan="1">Tc<em>&#x003b2;</em>3</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 25 <em>&#x003bc;</em>g</td><td align="center" rowspan="1" colspan="1">C57BL/6</td><td align="center" rowspan="1" colspan="1">IFN<em>&#x003b3;</em>, CTL</td><td align="center" rowspan="1" colspan="1">++</td><td align="center" rowspan="1" colspan="1">[<a href="#B96" rid="B96" class=" bibr popnode">96</a>]</td></tr><tr><td rowspan="1" colspan="1">Mucin (6 members)</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">2 &#x000d7; 25 <em>&#x003bc;</em>g</td><td align="center" rowspan="1" colspan="1">C57BL/6</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">&#x02012;</td><td align="center" rowspan="1" colspan="1">[<a href="#B96" rid="B96" class=" bibr popnode">96</a>]</td></tr><tr><td rowspan="1" colspan="1">KMP11</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">4 doses IM</td><td align="center" rowspan="1" colspan="1">BALB/c</td><td align="center" rowspan="1" colspan="1">CTL</td><td align="center" rowspan="1" colspan="1">&#x02012; to ++</td><td align="center" rowspan="1" colspan="1">[<a href="#B100" rid="B100" class=" bibr popnode">100</a>]</td></tr></tbody></table></div><div id="largeobj_idm139846342914016" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1940056/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF3"><p id="__p35" class="p p-first-last">IM: intramuscular; CTL: cytolytic activity; &#x02212;: no protection; +: little protection; ++: fair protection; +++: very good protection.</p></div></div></div><p id="__p19">As in <em>Leishmania</em> vaccine studies, a few authors addressed\nthe question of comparing protein and DNA vaccines encoding\nthe same antigen [<a href="#B90" rid="B90" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124476">90</a>, <a href="#B98" rid="B98" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124539">98</a>]. In A/Sn mice, immunization\nwith recombinant TS induced a higher antibody titer than TS\nDNA, but a comparable decrease in parasitemia. However,\nthe DNA vaccine was unable to increase survival, which the\nauthor attributed to the strain of the mice used, since this\nDNA vaccine was protective in BALB/c mice [<a href="#B90" rid="B90" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124518">90</a>]. On the\nother hand, immunization with recombinant CRP or CRP\nDNA induced a comparable Th1 immune response, but only\nthe DNA vaccine was protective against infection [<a href="#B98" rid="B98" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124525">98</a>].</p><p id="__p20">A number of other studies showed that DNA vaccines encoding\nvarious antigens could induce significant protection\nagainst <em>T. cruzi</em> infection, as evidenced by decreased parasitemia\nand improved survival of vaccinated mice (<a href="/pmc/articles/PMC1940056/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>).\nIn addition, a few studies also presented evidence of a reduction\nin cardiac tissue damage and inflammation at the\nhistopathologic level [<a href="#B87" rid="B87" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124440">87</a>, <a href="#B97" rid="B97" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124467">97</a>]. Furthermore, T cell analysis\nconfirmed that protection relied on CD8<sup>+</sup>T cells [<a href="#B84" rid="B84" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124435">84</a>, <a href="#B91" rid="B91" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124529">91</a>] and\nrecent studies showed that these cells were very rapidly activated\nfollowing infection of mice immunized with DNA vaccines\n[<a href="#B101" rid="B101" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124479">101</a>]. DNA vaccines based on defined T cell epitopes\nfrom TS antigen have also been tested and it was found that both CD4<sup>+</sup> and CD8<sup>+</sup>T cell epitopes were necessary and sufficient\nto induce a protective immune response [<a href="#B102" rid="B102" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124480">102</a>].</p><p id="__p21" class="p p-last">Taken together, these data clearly demonstrated that vaccination\ndid not result in increased pathology, as initially\nfeared, but allowed at least partial control of disease progression,\nthus confirming the central role of parasite persistence\nfor Chagas disease pathogenesis and opening the way to further\nassessment of DNA vaccines against <em>T. cruzi</em>. However, it\nhas to be noted that many of the antigens tested belonged to\nthe trans-sialidase family of protein, so that there is still little\ndiversity in terms of the antigens tested as vaccines against <em>T.\ncruzi</em> (<a href="/pmc/articles/PMC1940056/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>).</p></div><div id="subsec4.3" class="sec"><h3 id="subsec4.3title">4.3. Strategies for potentiating T. cruzi DNA vaccines</h3><p id="__p22" class="p p-first">Because protection induced by single antigen DNA vaccine\nremained partial, a number of studies have evaluated strategies\nto increase vaccine efficacy. These include the use of\ncytokine/chemokine encoding plasmids to potentiate the immune\nresponse induced by the vaccine, and two of the most\nstudied molecules have beens IL-12 and GM-CSF, which both\nwere generally able to potentiate protection (<a href="/pmc/articles/PMC1940056/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). Alternatively,\nmixtures of plasmids encoding distinct antigens\nwere used for immunization, and as mentioned above for\n<em>Leishmania</em> vaccines. For example, immunization of mice\nwith plasmids encoding TS and ASP-2 proteins resulted in\na specific immune response against both antigens and an increased\nprotection against infection [<a href="#B97" rid="B97" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124434">97</a>]. On the other hand,\nan immunization with a mixture of DNA vaccines encoding\nup to 6 proteins from the mucin family resulted poorly\nprotective, while a mixture of up to 7 proteins from the TS\nfamily was protective, but not as much as a single antigen\nvaccine encoding the TS-like antigen ASP-2 [<a href="#B96" rid="B96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124425">96</a>]. Similarly, a\nmixture of DNA vaccines encoding ASP-1, ASP-2, and TSA-1\nhad a similar protective activity as TSA-1 alone [<a href="#B87" rid="B87" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124511">87</a>]. The lack\nof efficacy of these multivalent vaccines may be attributed to\nthe presence of shared or immunodominant epitopes since\nthey have significant sequence similarity that may not have\nresulted in a broader immune reponse.</p><p id="__p23" class="p p-last">Heterologous prime-boost approach has also been evaluated\nand immunization with some combinations of DNA\nand recombinant TS was found to enhance Th1 immune\nresponse, but protection was not significantly different from\nthat obtained with DNA alone [<a href="#B103" rid="B103" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124490">103</a>]. Taken together, these\nstudies suggest that additional strategies need to be investigated\nto potentiate DNA vaccine efficacy against <em>T. cruzi</em>.</p></div><div id="subsec4.4" class="sec"><h3 id="subsec4.4title">4.4. Therapeutic DNA vaccines</h3><p id="__p24" class="p p-first-last">Therapeutic administration of DNA vaccines to control an\nongoing infection with <em>T. cruzi</em> may represent an additional alternative for Chagas disease control. The concept was\ndemonstrated in mice acutely or chronically infected, and\nin both cases the administration of only two doses of DNA\nvaccine encoding TSA-1 or Tc24 antigens was sufficient to\nlimit disease progression, as treated mice presented increased\nsurvival and reduced cardiac tissue damage, as assessed by\nhistopathologic analysis [<a href="#B104" rid="B104" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124493">104</a>]. A comparative study of different\nDNA vaccines identified Tc52 antigen as another therapeutic\nvaccine candidate, while DNA vaccines encoding antigens\nfrom the TS family previously found to be protective\nhad no signifiacnt therapeutic effect [<a href="#B105" rid="B105" class=" bibr popnode">105</a>]. It was found that\ntherapeutic vaccination rapidly induced spleen cell proliferation,\nincluding IFN<em>&#x003b3;</em>-producing CD4<sup>+</sup> and CD8<sup>+</sup>T cells,\nwhile the effects on cardiac tissue inflammation and parasite\nburden take longer to be detectable [<a href="#B106" rid="B106" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124465">106</a>]. Importantly, in\nall these studies, therapeutic vaccination of <em>T. cruzi</em> infected\nmice did not result in an increased inflammatory reaction in\nthe heart, confirming that it is safe to stimulate the immune\nresponse of <em>T. cruzi</em> infected mice and that attacking the parasite\ncan lead to a reduction of pathology. These studies thus\nopen very attractive perspectives for the control of <em>T. cruzi</em> infection,\nand further studies on the efficacy of DNA vaccines\nencoding other antigens and on the immune mechanisms\nunderlying their therapeutic effect should provide clues for\nthe optimization of this strategy.</p></div><div id="subsec4.5" class="sec sec-last"><h3 id="subsec4.5title">4.5. Antigen discovery</h3><p id="__p25" class="p p-first-last">As for any vaccine, the nature of the antigen used remains\na key factor for vaccine efficacy, and there is still little variety\nin terms of antigens evaluated as DNA vaccine candidates\nagainst <em>T. cruzi</em>. Thus, a number of studies have aimed\nat identifying novel antigens through various strategies. The\nmost classical approach has been the screening of cDNA\nlibraries using antibodies and screening an amastigote library\nallowed the identification of a novel antigen Tc<em>&#x003b2;</em>3, and\ntwo previously characterized ones, LYT1 and FcaBP/Tc24\n[<a href="#B96" rid="B96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124528">96</a>]. DNA vaccines encoding these antigens induced variable\nlevels of protection, the best one being LYT [<a href="#B96" rid="B96" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124422">96</a>]. Alternatively,\nexpression-library immunization, described above\nfor <em>Leishmania</em>, was also tested with <em>T. cruzi</em>, and found to\nbe immunogenic, but there was no attempt at fractionating\nthe library or identifying protective antigens [<a href="#B107" rid="B107" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124456">107</a>]. A likely\nreason is that such strategy may be too labor-intensive for\nlarge genomes/libraries, and its usefulness may be limited to\npathogens with small genomes. The availability of <em>T. cruzi</em>\ngenome sequence also opens new possibilities for antigen\ndiscovery. In one of the first studies using such resource, a\ncombination of bioinformatics analysis were used to identify\nGPI-anchored or secreted proteins, and most of the identified\nclones were immunogenic as DNA vaccines [<a href="#B108" rid="B108" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124433">108</a>]. Further\nstudies may confirm the usefulness of these new vaccines\nto protect against <em>T. cruzi</em> infection. Nonetheless, as discussed\nabove for <em>Leishmania</em>, the rationale for limiting antigen\nsearches to surface proteins may not be totally relevant,\nand additional strategies should also be used to include unbiaised\ngenome-wide surveys for antigen discovery.</p></div></div><div id="sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="sec5title">5. FUTURE DIRECTIONS</h2><p id="__p26" class="p p-first">As detailed in this review, there have been considerable advances\nin DNA vaccines against <em>Leishmania</em> and <em>T. cruzi</em> in recent\nyears. Taken together, these studies clearly validated the\nconcept of using DNA vaccines for both protection and therapy\nagainst these protozoan parasites in a variety of mouse\nmodels. While sterile immunity seems to be an irrealistic\ngoal for either <em>Leishmania</em> or <em>T. cruzi</em>, a reduction in disease\nseverity and in the development of the pathology seems\nclearly within the reach of DNA vaccines. Nonetheless, the\nrelevance of such mouse models for the development of veterinary\nor human vaccines against these parasites has been\nchallenged by some authors. The few DNA vaccine studies\nin nonmurine models of Leishmaniasis suggest that some extrapolation may\nbe feasible, but certainly not completely. Additional\nadvanced preclinical studies of DNA vaccine candidates\nin nonmurine animal models such as rats, hamsters,\ndogs, or monkeys are thus warranted in the next few years, to\nfurther explore the immunology and efficacy of DNA vaccines\nagainst these parasites. As already observed in such\nstudies for other pathogens, this will lead to the challenge of\nachieving in these species an immunogenicity of comparable\nlevel and protective efficacy as that obtained in murine models.\nHowever, advances in adjuvants, DNA vaccine formulation,\nand delivery systems are likely to contribute to such results\n[<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124520">1</a>, <a href="#B109" rid="B109" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124537">109</a>].</p><p id="__p27">Another major issue is that of antigen discovery, and\nwhile a number of DNA vacines tested so far against <em>Leishmania</em>\nor <em>T. cruzi</em> have shown promise, we are still unsure if\nthese are the best possible antigens, particularly since these\nparasites have relatively large genomes, and only a limited\nvariety of antigens have been tested. The availability of the\ngenome sequences of these parasites will without doubt be\na key resource for genome-wide screenings for new protective\nantigens. A key lesson from the initial studies reviewed\nhere [<a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124531">48</a>, <a href="#B51" rid="B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124474">51</a>, <a href="#B108" rid="B108" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124464">108</a>], together with other similar antigen discovery\nstudies, seems to be that cellular localization and protein\nfunction are poor predictors of the antigenicity and protective\nefficacy of a protein. Alternative criteria should thus be\nused so that potent vaccine candidates are not missed, and\nthe important development of genome-mining and bioinformatic\ntools is providing new tools for a more rational search\nof vaccine candidates [<a href="#B110" rid="B110" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_145124524">110</a>].</p><p id="__p28" class="p p-last">To conclude, those DNA vaccines represent a promising\napproach for the control of <em>Leishmania</em> sp. and <em>T. cruzi</em>, and\nsuch vaccines would have a major impact in developing endemic\ncountries. Thus the question does not seem to be if\nDNA vaccines can control these parasites, since many studies\nhave clearly showed that this is the case, but how to translate\nwhat has been achieved in mouse models into veterinary or\nhuman vaccines of comparable efficacy.</p></div><div id="idm139846270375792" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139846270375792title">ACKNOWLEDGMENT</h2><div class="sec"><p id="__p29">This work was funded by Grant SEP-2004-C01-47122 from\nthe Consejo Nacional de Ciencia y Tecnolog&#x000ed;a (CONACYT).</p></div></div><div id="idm139846270374656" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139846270374656title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="citation">Liu MA, Wahren B, Hedestam GBK. DNA vaccines: recent developments and future possibilities. <span><span class="ref-journal"><em>Human Gene Therapy</em>. </span>2006;<span class="ref-vol">17</span>(11):1051\xe2\x80\x931061.</span> [<a href="/pubmed/17032152" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Gene+Therapy&amp;title=DNA+vaccines:+recent+developments+and+future+possibilities&amp;author=MA+Liu&amp;author=B+Wahren&amp;author=GBK+Hedestam&amp;volume=17&amp;issue=11&amp;publication_year=2006&amp;pages=1051-1061&amp;pmid=17032152&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="citation">Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. <span><span class="ref-journal"><em>The Lancet</em>. </span>2005;<span class="ref-vol">366</span>(9496):1561\xe2\x80\x931577.</span> [<a href="/pubmed/16257344" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Lancet&amp;title=Advances+in+leishmaniasis&amp;author=HW+Murray&amp;author=JD+Berman&amp;author=CR+Davies&amp;author=NG+Saravia&amp;volume=366&amp;issue=9496&amp;publication_year=2005&amp;pages=1561-1577&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="citation">Alexander J, Bryson K. T helper (h)1/Th2 and <em>Leishmania</em>: paradox rather than paradigm. <span><span class="ref-journal"><em>Immunology Letters</em>. </span>2005;<span class="ref-vol">99</span>(1):17\xe2\x80\x9323.</span> [<a href="/pubmed/15894106" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunology+Letters&amp;title=T+helper+(h)1/Th2+and+Leishmania:+paradox+rather+than+paradigm&amp;author=J+Alexander&amp;author=K+Bryson&amp;volume=99&amp;issue=1&amp;publication_year=2005&amp;pages=17-23&amp;pmid=15894106&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="citation">McMahon-Pratt D, Alexander J. Does the <em>Leishmania major</em> paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? <span><span class="ref-journal"><em>Immunological Reviews</em>. </span>2004;<span class="ref-vol">201</span>(1):206\xe2\x80\x93224.</span> [<a href="/pubmed/15361243" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunological+Reviews&amp;title=Does+the+Leishmania+major+paradigm+of+pathogenesis+and+protection+hold+for+New+World+cutaneous+leishmaniases+or+the+visceral+disease?&amp;author=D+McMahon-Pratt&amp;author=J+Alexander&amp;volume=201&amp;issue=1&amp;publication_year=2004&amp;pages=206-224&amp;pmid=15361243&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="citation">Castro JA, de Mecca MM, Bartel LC. Toxic side effects of drugs used to treat Chagas\' disease (American trypanosomiasis) <span><span class="ref-journal"><em>Human and Experimental Toxicology</em>. </span>2006;<span class="ref-vol">25</span>(8):471\xe2\x80\x93479.</span> [<a href="/pubmed/16937919" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+and+Experimental+Toxicology&amp;title=Toxic+side+effects+of+drugs+used+to+treat+Chagas\'+disease+(American+trypanosomiasis)&amp;author=JA+Castro&amp;author=MM+de+Mecca&amp;author=LC+Bartel&amp;volume=25&amp;issue=8&amp;publication_year=2006&amp;pages=471-479&amp;pmid=16937919&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="citation">Sheets RL, Stein J, Manetz TS, et al.  Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts. <span><span class="ref-journal"><em>Toxicological Sciences</em>. </span>2006;<span class="ref-vol">91</span>(2):610\xe2\x80\x93619.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2377020/">PMC free article</a>]</span> [<a href="/pubmed/16569729" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicological+Sciences&amp;title=Biodistribution+of+DNA+plasmid+vaccines+against+HIV-1,+Ebola,+Severe+Acute+Respiratory+Syndrome,+or+West+Nile+virus+is+similar,+without+integration,+despite+differing+plasmid+backbones+or+gene+inserts&amp;author=RL+Sheets&amp;author=J+Stein&amp;author=TS+Manetz&amp;volume=91&amp;issue=2&amp;publication_year=2006&amp;pages=610-619&amp;pmid=16569729&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="citation">Sheets RL, Stein J, Manetz TS, et al.  Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts. <span><span class="ref-journal"><em>Toxicological Sciences</em>. </span>2006;<span class="ref-vol">91</span>(2):620\xe2\x80\x93630.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2366098/">PMC free article</a>]</span> [<a href="/pubmed/16569728" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicological+Sciences&amp;title=Toxicological+safety+evaluation+of+DNA+plasmid+vaccines+against+HIV-1,+Ebola,+Severe+Acute+Respiratory+Syndrome,+or+West+Nile+virus+is+similar+despite+differing+plasmid+backbones+or+gene-inserts&amp;author=RL+Sheets&amp;author=J+Stein&amp;author=TS+Manetz&amp;volume=91&amp;issue=2&amp;publication_year=2006&amp;pages=620-630&amp;pmid=16569728&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="citation">Louis J, Himmelrich H, Parra-Lopez C, Tacchini-Cottier F, Launois P. Regulation of protective immunity against <em>Leishmania major</em> in mice. <span><span class="ref-journal"><em>Current Opinion in Immunology</em>. </span>1998;<span class="ref-vol">10</span>(4):459\xe2\x80\x93464.</span> [<a href="/pubmed/9722923" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Opinion+in+Immunology&amp;title=Regulation+of+protective+immunity+against+Leishmania+major+in+mice&amp;author=J+Louis&amp;author=H+Himmelrich&amp;author=C+Parra-Lopez&amp;author=F+Tacchini-Cottier&amp;author=P+Launois&amp;volume=10&amp;issue=4&amp;publication_year=1998&amp;pages=459-464&amp;pmid=9722923&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="citation">Miles SA, Conrad SM, Alves RG, Jeronimo SMB, Mosser DM. A role for IgG immune complexes during infection with the intracellular pathogen <em>Leishmania</em>\n. <span><span class="ref-journal"><em>The Journal of Experimental Medicine</em>. </span>2005;<span class="ref-vol">201</span>(5):747\xe2\x80\x93754.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1351290/">PMC free article</a>]</span> [<a href="/pubmed/15753208" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Experimental+Medicine&amp;title=A+role+for+IgG+immune+complexes+during+infection+with+the+intracellular+pathogen+Leishmania&#10;&amp;author=SA+Miles&amp;author=SM+Conrad&amp;author=RG+Alves&amp;author=SMB+Jeronimo&amp;author=DM+Mosser&amp;volume=201&amp;issue=5&amp;publication_year=2005&amp;pages=747-754&amp;pmid=15753208&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="citation">St&#x000e4;ger S, Alexander J, Kirby AC, et al.  Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8<sup>+</sup> T-cell responses. <span><span class="ref-journal"><em>Nature Medicine</em>. </span>2003;<span class="ref-vol">9</span>(10):1287\xe2\x80\x931292.</span> [<a href="/pubmed/14502281" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Medicine&amp;title=Natural+antibodies+and+complement+are+endogenous+adjuvants+for+vaccine-induced+CD8++T-cell+responses&amp;author=S+St&#x000e4;ger&amp;author=J+Alexander&amp;author=AC+Kirby&amp;volume=9&amp;issue=10&amp;publication_year=2003&amp;pages=1287-1292&amp;pmid=14502281&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="citation">Woelbing F, Kostka SL, Moelle K, et al.  Uptake of <em>Leishmania major</em> by dendritic cells is mediated by Fc<em>&#x003b3;</em> receptors and facilitates acquisition of protective immunity. <span><span class="ref-journal"><em>The Journal of Experimental Medicine</em>. </span>2006;<span class="ref-vol">203</span>(1):177\xe2\x80\x93188.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2118064/">PMC free article</a>]</span> [<a href="/pubmed/16418399" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Experimental+Medicine&amp;title=Uptake+of+Leishmania+major+by+dendritic+cells+is+mediated+by+Fc&#x003b3;+receptors+and+facilitates+acquisition+of+protective+immunity&amp;author=F+Woelbing&amp;author=SL+Kostka&amp;author=K+Moelle&amp;volume=203&amp;issue=1&amp;publication_year=2006&amp;pages=177-188&amp;pmid=16418399&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="citation">Bogdan C, R&#x000f6;llinghoff M. The immune response to <em>Leishmania</em>: mechanisms of parasite control and evasion. <span><span class="ref-journal"><em>International Journal for Parasitology</em>. </span>1998;<span class="ref-vol">28</span>(1):121\xe2\x80\x93134.</span> [<a href="/pubmed/9504340" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+Journal+for+Parasitology&amp;title=The+immune+response+to+Leishmania:+mechanisms+of+parasite+control+and+evasion&amp;author=C+Bogdan&amp;author=M+R&#x000f6;llinghoff&amp;volume=28&amp;issue=1&amp;publication_year=1998&amp;pages=121-134&amp;pmid=9504340&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="citation">M&#x000e9;ndez S, Belkaid Y, Seder RA, Sacks D. Optimization of DNA vaccination against cutaneous leishmaniasis. <span><span class="ref-journal"><em>Vaccine</em>. </span>2002;<span class="ref-vol">20</span>(31-32):3702\xe2\x80\x933708.</span> [<a href="/pubmed/12399198" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Optimization+of+DNA+vaccination+against+cutaneous+leishmaniasis&amp;author=S+M&#x000e9;ndez&amp;author=Y+Belkaid&amp;author=RA+Seder&amp;author=D+Sacks&amp;volume=20&amp;issue=31-32&amp;publication_year=2002&amp;pages=3702-3708&amp;pmid=12399198&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="citation">Walker PS. American Academy of Dermatology 1997 Awards for Young Investigators in Dermatology. Direct targeting of skin with DNA vaccines for genetic immunization against <em>Leishmania</em> in a murine model. <span><span class="ref-journal"><em>Journal of the American Academy of Dermatology</em>. </span>1997;<span class="ref-vol">37</span>(5, part 1):776\xe2\x80\x93777.</span> [<a href="/pubmed/9366829" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+the+American+Academy+of+Dermatology&amp;title=American+Academy+of+Dermatology+1997+Awards+for+Young+Investigators+in+Dermatology.+Direct+targeting+of+skin+with+DNA+vaccines+for+genetic+immunization+against+Leishmania+in+a+murine+model&amp;author=PS+Walker&amp;volume=37&amp;issue=5,+part+1&amp;publication_year=1997&amp;pages=776-777&amp;pmid=9366829&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="citation">Walker PS, Scharton-Kersten T, Rowton ED, et al.  Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis. <span><span class="ref-journal"><em>Human Gene Therapy</em>. </span>1998;<span class="ref-vol">9</span>(13):1899\xe2\x80\x931907.</span> [<a href="/pubmed/9741428" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Gene+Therapy&amp;title=Genetic+immunization+with+glycoprotein+63+cDNA+results+in+a+helper+T+cell+type+1+immune+response+and+protection+in+a+murine+model+of+leishmaniasis&amp;author=PS+Walker&amp;author=T+Scharton-Kersten&amp;author=ED+Rowton&amp;volume=9&amp;issue=13&amp;publication_year=1998&amp;pages=1899-1907&amp;pmid=9741428&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="citation">Xu D, Liew FY. Genetic vaccination against leishmaniasis. <span><span class="ref-journal"><em>Vaccine</em>. </span>1994;<span class="ref-vol">12</span>(16):1534\xe2\x80\x931536.</span> [<a href="/pubmed/7879420" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Genetic+vaccination+against+leishmaniasis&amp;author=D+Xu&amp;author=FY+Liew&amp;volume=12&amp;issue=16&amp;publication_year=1994&amp;pages=1534-1536&amp;pmid=7879420&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="citation">Xu D, Liew FY. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of <em>L. major</em>\n. <span><span class="ref-journal"><em>Immunology</em>. </span>1995;<span class="ref-vol">84</span>(2):173\xe2\x80\x93176.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1415107/">PMC free article</a>]</span> [<a href="/pubmed/7750991" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=Protection+against+leishmaniasis+by+injection+of+DNA+encoding+a+major+surface+glycoprotein,+gp63,+of+L.+major&#10;&amp;author=D+Xu&amp;author=FY+Liew&amp;volume=84&amp;issue=2&amp;publication_year=1995&amp;pages=173-176&amp;pmid=7750991&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="citation">Gurunathan S, Sacks DL, Brown DR, et al.  Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with <em>Leishmania major</em>\n. <span><span class="ref-journal"><em>The Journal of Experimental Medicine</em>. </span>1997;<span class="ref-vol">186</span>(7):1137\xe2\x80\x931147.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2199076/">PMC free article</a>]</span> [<a href="/pubmed/9314562" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Experimental+Medicine&amp;title=Vaccination+with+DNA+encoding+the+immunodominant+LACK+parasite+antigen+confers+protective+immunity+to+mice+infected+with+Leishmania+major&#10;&amp;author=S+Gurunathan&amp;author=DL+Sacks&amp;author=DR+Brown&amp;volume=186&amp;issue=7&amp;publication_year=1997&amp;pages=1137-1147&amp;pmid=9314562&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="citation">Gurunathan S, Prussin C, Sacks DL, Seder RA. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. <span><span class="ref-journal"><em>Nature Medicine</em>. </span>1998;<span class="ref-vol">4</span>(12):1409\xe2\x80\x931415.</span> [<a href="/pubmed/9846579" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Medicine&amp;title=Vaccine+requirements+for+sustained+cellular+immunity+to+an+intracellular+parasitic+infection&amp;author=S+Gurunathan&amp;author=C+Prussin&amp;author=DL+Sacks&amp;author=RA+Seder&amp;volume=4&amp;issue=12&amp;publication_year=1998&amp;pages=1409-1415&amp;pmid=9846579&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="citation">Gurunathan S, Stobie L, Prussin C, et al.  Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8<sup>+</sup> T cells. <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>2000;<span class="ref-vol">165</span>(2):915\xe2\x80\x93924.</span> [<a href="/pubmed/10878366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=Requirements+for+the+maintenance+of+Th1+immunity+in+vivo+following+DNA+vaccination:+a+potential+immunoregulatory+role+for+CD8++T+cells&amp;author=S+Gurunathan&amp;author=L+Stobie&amp;author=C+Prussin&amp;volume=165&amp;issue=2&amp;publication_year=2000&amp;pages=915-924&amp;pmid=10878366&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="citation">Stobie L, Gurunathan S, Prussin C, et al.  The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. <span><span class="ref-journal"><em>Proceedings of the National Academy of Sciences of the United States of America</em>. </span>2000;<span class="ref-vol">97</span>(15):8427\xe2\x80\x938432.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC26964/">PMC free article</a>]</span> [<a href="/pubmed/10890924" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;title=The+role+of+antigen+and+IL-12+in+sustaining+Th1+memory+cells+in+vivo:+IL-12+is+required+to+maintain+memory/effector+Th1+cells+sufficient+to+mediate+protection+to+an+infectious+parasite+challenge&amp;author=L+Stobie&amp;author=S+Gurunathan&amp;author=C+Prussin&amp;volume=97&amp;issue=15&amp;publication_year=2000&amp;pages=8427-8432&amp;pmid=10890924&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="citation">Iborra S, Soto M, Carri&#x000f3;n J, Alonso C, Requena JM. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of <em>Leishmania</em> confers protection against murine cutaneous leishmaniosis. <span><span class="ref-journal"><em>Vaccine</em>. </span>2004;<span class="ref-vol">22</span>(29-30):3865\xe2\x80\x933876.</span> [<a href="/pubmed/15364433" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Vaccination+with+a+plasmid+DNA+cocktail+encoding+the+nucleosomal+histones+of+Leishmania+confers+protection+against+murine+cutaneous+leishmaniosis&amp;author=S+Iborra&amp;author=M+Soto&amp;author=J+Carri&#x000f3;n&amp;author=C+Alonso&amp;author=JM+Requena&amp;volume=22&amp;issue=29-30&amp;publication_year=2004&amp;pages=3865-3876&amp;pmid=15364433&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="citation">Dumonteil E, Ramirez-Sierra MJ, Escobedo-Ortegonr J, Garc&#x000ed;a-Miss MR. DNA vaccines induce partial protection against <em>Leishmania mexicana</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>2003;<span class="ref-vol">21</span>(17-18):2161\xe2\x80\x932168.</span> [<a href="/pubmed/12706707" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=DNA+vaccines+induce+partial+protection+against+Leishmania+mexicana&#10;&amp;author=E+Dumonteil&amp;author=MJ+Ramirez-Sierra&amp;author=J+Escobedo-Ortegonr&amp;author=MR+Garc&#x000ed;a-Miss&amp;volume=21&amp;issue=17-18&amp;publication_year=2003&amp;pages=2161-2168&amp;pmid=12706707&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="citation">Marques-da-Silva EA, Coelho EAF, Gomes DCO, et al.  Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-<em>&#x003b3;</em> production but does not protect BALB/c mice against <em>Leishmania chagasi</em> intravenous challenge. <span><span class="ref-journal"><em>Parasitology Research</em>. </span>2005;<span class="ref-vol">98</span>(1):67\xe2\x80\x9374.</span> [<a href="/pubmed/16261353" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Parasitology+Research&amp;title=Intramuscular+immunization+with+p36(LACK)+DNA+vaccine+induces+IFN-&#x003b3;+production+but+does+not+protect+BALB/c+mice+against+Leishmania+chagasi+intravenous+challenge&amp;author=EA+Marques-da-Silva&amp;author=EAF+Coelho&amp;author=DCO+Gomes&amp;volume=98&amp;issue=1&amp;publication_year=2005&amp;pages=67-74&amp;pmid=16261353&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="citation">Melby PC, Yang J, Zhao W, Perez LE, Cheng J. \n<em>Leishmania donovani</em> p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2001;<span class="ref-vol">69</span>(8):4719\xe2\x80\x934725.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC98557/">PMC free article</a>]</span> [<a href="/pubmed/11447143" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=&#10;Leishmania+donovani+p36(LACK)+DNA+vaccine+is+highly+immunogenic+but+not+protective+against+experimental+visceral+leishmaniasis&amp;author=PC+Melby&amp;author=J+Yang&amp;author=W+Zhao&amp;author=LE+Perez&amp;author=J+Cheng&amp;volume=69&amp;issue=8&amp;publication_year=2001&amp;pages=4719-4725&amp;pmid=11447143&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="citation">Gonzalo RM, del Real G, Rodriguez JR, et al.  A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the <em>Leishmania infantum</em> P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis. <span><span class="ref-journal"><em>Vaccine</em>. </span>2002;<span class="ref-vol">20</span>(7-8):1226\xe2\x80\x931231.</span> [<a href="/pubmed/11803085" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=A+heterologous+prime-boost+regime+using+DNA+and+recombinant+vaccinia+virus+expressing+the+Leishmania+infantum+P36/LACK+antigen+protects+BALB/c+mice+from+cutaneous+leishmaniasis&amp;author=RM+Gonzalo&amp;author=G+del+Real&amp;author=JR+Rodriguez&amp;volume=20&amp;issue=7-8&amp;publication_year=2002&amp;pages=1226-1231&amp;pmid=11803085&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="citation">Tapia E, P&#x000e9;rez-Jim&#x000e9;nez E, L&#x000f3;pez-Fuertes L, Gonzalo R, Gherardi MM, Esteban M. The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK. <span><span class="ref-journal"><em>Microbes and Infection</em>. </span>2003;<span class="ref-vol">5</span>(2):73\xe2\x80\x9384.</span> [<a href="/pubmed/12650765" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbes+and+Infection&amp;title=The+combination+of+DNA+vectors+expressing+IL-12+++IL-18+elicits+high+protective+immune+response+against+cutaneous+leishmaniasis+after+priming+with+DNA-p36/LACK+and+the+cytokines,+followed+by+a+booster+with+a+vaccinia+virus+recombinant+expressing+p36/LACK&amp;author=E+Tapia&amp;author=E+P&#x000e9;rez-Jim&#x000e9;nez&amp;author=L+L&#x000f3;pez-Fuertes&amp;author=R+Gonzalo&amp;author=MM+Gherardi&amp;volume=5&amp;issue=2&amp;publication_year=2003&amp;pages=73-84&amp;pmid=12650765&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="citation">P&#x000e9;rez-Jim&#x000e9;nez E, Kochan G, Gherardi MM, Esteban M. MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis. <span><span class="ref-journal"><em>Microbes and Infection</em>. </span>2006;<span class="ref-vol">8</span>(3):810\xe2\x80\x93822.</span> [<a href="/pubmed/16504562" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbes+and+Infection&amp;title=MVA-LACK+as+a+safe+and+efficient+vector+for+vaccination+against+leishmaniasis&amp;author=E+P&#x000e9;rez-Jim&#x000e9;nez&amp;author=G+Kochan&amp;author=MM+Gherardi&amp;author=M+Esteban&amp;volume=8&amp;issue=3&amp;publication_year=2006&amp;pages=810-822&amp;pmid=16504562&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="citation">Dondji B, P&#x000e9;rez-Jimenez E, Goldsmith-Pestana K, Esteban M, McMahon-Pratt D. Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2005;<span class="ref-vol">73</span>(8):5286\xe2\x80\x935289.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1201228/">PMC free article</a>]</span> [<a href="/pubmed/16041057" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Heterologous+prime-boost+vaccination+with+the+LACK+antigen+protects+against+murine+visceral+leishmaniasis&amp;author=B+Dondji&amp;author=E+P&#x000e9;rez-Jimenez&amp;author=K+Goldsmith-Pestana&amp;author=M+Esteban&amp;author=D+McMahon-Pratt&amp;volume=73&amp;issue=8&amp;publication_year=2005&amp;pages=5286-5289&amp;pmid=16041057&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="citation">Stober CB, Lange UG, Roberts MTM, Alcami A, Blackwell JM. Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against <em>Leishmania major</em> in susceptible BALB/c mice. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2007;<span class="ref-vol">75</span>(2):852\xe2\x80\x93860.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1828487/">PMC free article</a>]</span> [<a href="/pubmed/17101647" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Heterologous+priming-boosting+with+DNA+and+modified+vaccinia+virus+Ankara+expressing+tryparedoxin+peroxidase+promotes+long-term+memory+against+Leishmania+major+in+susceptible+BALB/c+mice&amp;author=CB+Stober&amp;author=UG+Lange&amp;author=MTM+Roberts&amp;author=A+Alcami&amp;author=JM+Blackwell&amp;volume=75&amp;issue=2&amp;publication_year=2007&amp;pages=852-860&amp;pmid=17101647&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="citation">Iborra S, Soto M, Carri&#x000f3;n J, et al.  The <em>Leishmania infantum</em> acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to <em>Leishmania major</em> infection in BALB/c mice. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2003;<span class="ref-vol">71</span>(11):6562\xe2\x80\x936572.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC219595/">PMC free article</a>]</span> [<a href="/pubmed/14573678" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=The+Leishmania+infantum+acidic+ribosomal+protein+P0+administered+as+a+DNA+vaccine+confers+protective+immunity+to+Leishmania+major+infection+in+BALB/c+mice&amp;author=S+Iborra&amp;author=M+Soto&amp;author=J+Carri&#x000f3;n&amp;volume=71&amp;issue=11&amp;publication_year=2003&amp;pages=6562-6572&amp;pmid=14573678&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="citation">Rafati S, Ghaemimanesh F, Zahedifard F. Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against <em>Leishmania major</em> infection using Signal Peptidase type I in BALB/c mice. <span><span class="ref-journal"><em>Vaccine</em>. </span>2006;<span class="ref-vol">24</span>(16):3290\xe2\x80\x933297.</span> [<a href="/pubmed/16481076" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Comparison+of+potential+protection+induced+by+three+vaccination+strategies+(DNA/DNA,+Protein/Protein+and+DNA/Protein)+against+Leishmania+major+infection+using+Signal+Peptidase+type+I+in+BALB/c+mice&amp;author=S+Rafati&amp;author=F+Ghaemimanesh&amp;author=F+Zahedifard&amp;volume=24&amp;issue=16&amp;publication_year=2006&amp;pages=3290-3297&amp;pmid=16481076&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="citation">Campos-Neto A, Webb JR, Greeson K, Coler RN, Skeiky YAW, Reed SG. Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against <em>Leishmania major</em> infection in susceptible BALB/c mice. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2002;<span class="ref-vol">70</span>(6):2828\xe2\x80\x932836.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC128002/">PMC free article</a>]</span> [<a href="/pubmed/12010969" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Vaccination+with+plasmid+DNA+encoding+TSA/LmSTI1+leishmanial+fusion+proteins+confers+protection+against+Leishmania+major+infection+in+susceptible+BALB/c+mice&amp;author=A+Campos-Neto&amp;author=JR+Webb&amp;author=K+Greeson&amp;author=RN+Coler&amp;author=YAW+Skeiky&amp;volume=70&amp;issue=6&amp;publication_year=2002&amp;pages=2828-2836&amp;pmid=12010969&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="citation">Rafati S, Salmanian A-H, Taheri T, Vafa M, Fasel N. A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of <em>Leishmania major</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>2001;<span class="ref-vol">19</span>(25-26):3369\xe2\x80\x933375.</span> [<a href="/pubmed/11348700" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=A+protective+cocktail+vaccine+against+murine+cutaneous+leishmaniasis+with+DNA+encoding+cysteine+proteinases+of+Leishmania+major&#10;&amp;author=S+Rafati&amp;author=A-H+Salmanian&amp;author=T+Taheri&amp;author=M+Vafa&amp;author=N+Fasel&amp;volume=19&amp;issue=25-26&amp;publication_year=2001&amp;pages=3369-3375&amp;pmid=11348700&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="citation">Sj&#x000f6;lander A, Baldwin TM, Curtis JM, Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>1998;<span class="ref-vol">160</span>(8):3949\xe2\x80\x933957.</span> [<a href="/pubmed/9558102" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=Induction+of+a+Th1+immune+response+and+simultaneous+lack+of+activation+of+a+Th2+response+are+required+for+generation+of+immunity+to+leishmaniasis&amp;author=A+Sj&#x000f6;lander&amp;author=TM+Baldwin&amp;author=JM+Curtis&amp;author=E+Handman&amp;volume=160&amp;issue=8&amp;publication_year=1998&amp;pages=3949-3957&amp;pmid=9558102&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="citation">Ahmed SBH, Bahloul C, Robbana C, Askri S, Dellagi K. A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to <em>L. major</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>2004;<span class="ref-vol">22</span>(13-14):1631\xe2\x80\x931639.</span> [<a href="/pubmed/15068845" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=A+comparative+evaluation+of+different+DNA+vaccine+candidates+against+experimental+murine+leishmaniasis+due+to+L.+major&#10;&amp;author=SBH+Ahmed&amp;author=C+Bahloul&amp;author=C+Robbana&amp;author=S+Askri&amp;author=K+Dellagi&amp;volume=22&amp;issue=13-14&amp;publication_year=2004&amp;pages=1631-1639&amp;pmid=15068845&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="citation">Serezani CHC, Franco AR, Wajc M, et al.  Evaluation of the murine immune response to <em>Leishmania</em> meta 1 antigen delivered as recombinant protein or DNA vaccine. <span><span class="ref-journal"><em>Vaccine</em>. </span>2002;<span class="ref-vol">20</span>(31-32):3755\xe2\x80\x933763.</span> [<a href="/pubmed/12399206" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Evaluation+of+the+murine+immune+response+to+Leishmania+meta+1+antigen+delivered+as+recombinant+protein+or+DNA+vaccine&amp;author=CHC+Serezani&amp;author=AR+Franco&amp;author=M+Wajc&amp;volume=20&amp;issue=31-32&amp;publication_year=2002&amp;pages=3755-3763&amp;pmid=12399206&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="citation">Campbell K, Diao H, Ji J, Soong L. DNA immunization with the gene encoding P4 nuclease of <em>Leishmania amazonensis</em> protects mice against cutaneous leishmaniasis. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2003;<span class="ref-vol">71</span>(11):6270\xe2\x80\x936278.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC219588/">PMC free article</a>]</span> [<a href="/pubmed/14573646" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=DNA+immunization+with+the+gene+encoding+P4+nuclease+of+Leishmania+amazonensis+protects+mice+against+cutaneous+leishmaniasis&amp;author=K+Campbell&amp;author=H+Diao&amp;author=J+Ji&amp;author=L+Soong&amp;volume=71&amp;issue=11&amp;publication_year=2003&amp;pages=6270-6278&amp;pmid=14573646&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="citation">Dumonteil E, Andrade-Narvarez F, Escobedo-Ortegon J, et al.  Comparative study of DNA vaccines encoding various antigens against <em>Leishmania mexicana</em>\n. <span><span class="ref-journal"><em>Developments in Biologicals</em>. </span>2000;<span class="ref-vol">104</span>:135\xe2\x80\x93141.</span> [<a href="/pubmed/11713811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Developments+in+Biologicals&amp;title=Comparative+study+of+DNA+vaccines+encoding+various+antigens+against+Leishmania+mexicana&#10;&amp;author=E+Dumonteil&amp;author=F+Andrade-Narvarez&amp;author=J+Escobedo-Ortegon&amp;volume=104&amp;publication_year=2000&amp;pages=135-141&amp;pmid=11713811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="citation">Aguilar-Be I, da Silva Zardo R, Paraguai de Souza E, et al.  Cross-protective efficacy of a prophylactic <em>Leishmania donovani</em> DNA vaccine against visceral and cutaneous murine leishmaniasis. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2005;<span class="ref-vol">73</span>(2):812\xe2\x80\x93819.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC547025/">PMC free article</a>]</span> [<a href="/pubmed/15664920" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Cross-protective+efficacy+of+a+prophylactic+Leishmania+donovani+DNA+vaccine+against+visceral+and+cutaneous+murine+leishmaniasis&amp;author=I+Aguilar-Be&amp;author=R+da+Silva+Zardo&amp;author=E+Paraguai+de+Souza&amp;volume=73&amp;issue=2&amp;publication_year=2005&amp;pages=812-819&amp;pmid=15664920&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="citation">Rosado-Vallado M, Mut-Martin M, Garc&#x000ed;a-Miss MR, Dumonteil E. Aluminium phosphate potentiates the efficacy of DNA vaccines against <em>Leishmania mexicana</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>2005;<span class="ref-vol">23</span>(46-47):5372\xe2\x80\x935379.</span> [<a href="/pubmed/16054271" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Aluminium+phosphate+potentiates+the+efficacy+of+DNA+vaccines+against+Leishmania+mexicana&#10;&amp;author=M+Rosado-Vallado&amp;author=M+Mut-Martin&amp;author=MR+Garc&#x000ed;a-Miss&amp;author=E+Dumonteil&amp;volume=23&amp;issue=46-47&amp;publication_year=2005&amp;pages=5372-5379&amp;pmid=16054271&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="citation">Rafati S, Zahedifard F, Nazgouee F. Prime-boost vaccination using cysteine proteinases type I and II of <em>Leishmania infantum</em> confers protective immunity in murine visceral leishmaniasis. <span><span class="ref-journal"><em>Vaccine</em>. </span>2006;<span class="ref-vol">24</span>(12):2169\xe2\x80\x932175.</span> [<a href="/pubmed/16325969" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Prime-boost+vaccination+using+cysteine+proteinases+type+I+and+II+of+Leishmania+infantum+confers+protective+immunity+in+murine+visceral+leishmaniasis&amp;author=S+Rafati&amp;author=F+Zahedifard&amp;author=F+Nazgouee&amp;volume=24&amp;issue=12&amp;publication_year=2006&amp;pages=2169-2175&amp;pmid=16325969&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="citation">Sukumaran B, Tewary P, Saxena S, Madhubala R. Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with <em>Leishmania donovani</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>2003;<span class="ref-vol">21</span>(11-12):1292\xe2\x80\x931299.</span> [<a href="/pubmed/12559811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Vaccination+with+DNA+encoding+ORFF+antigen+confers+protective+immunity+in+mice+infected+with+Leishmania+donovani&#10;&amp;author=B+Sukumaran&amp;author=P+Tewary&amp;author=S+Saxena&amp;author=R+Madhubala&amp;volume=21&amp;issue=11-12&amp;publication_year=2003&amp;pages=1292-1299&amp;pmid=12559811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="citation">Sj&#x000f6;lander A, Baldwin TM, Curtis JM, Bengtsson KL, Handman E. Vaccination with recombinant Parasite Surface Antigen 2 from <em>Leishmania major</em> induces a Th1 type of immune response but does not protect against infection. <span><span class="ref-journal"><em>Vaccine</em>. </span>1998;<span class="ref-vol">16</span>(20):2077\xe2\x80\x932084.</span> [<a href="/pubmed/9796067" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Vaccination+with+recombinant+Parasite+Surface+Antigen+2+from+Leishmania+major+induces+a+Th1+type+of+immune+response+but+does+not+protect+against+infection&amp;author=A+Sj&#x000f6;lander&amp;author=TM+Baldwin&amp;author=JM+Curtis&amp;author=KL+Bengtsson&amp;author=E+Handman&amp;volume=16&amp;issue=20&amp;publication_year=1998&amp;pages=2077-2084&amp;pmid=9796067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="citation">M&#x000e9;ndez S, Gurunathan S, Kamhawi S, et al.  The potency and durability of DNA- and protein-based vaccines against <em>Leishmania major</em> evaluated using low-dose, intradermal challenge. <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>2001;<span class="ref-vol">166</span>(8):5122\xe2\x80\x935128.</span> [<a href="/pubmed/11290794" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=The+potency+and+durability+of+DNA-+and+protein-based+vaccines+against+Leishmania+major+evaluated+using+low-dose,+intradermal+challenge&amp;author=S+M&#x000e9;ndez&amp;author=S+Gurunathan&amp;author=S+Kamhawi&amp;volume=166&amp;issue=8&amp;publication_year=2001&amp;pages=5122-5128&amp;pmid=11290794&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="citation">Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. <span><span class="ref-journal"><em>Nature</em>. </span>1995;<span class="ref-vol">377</span>(6550):632\xe2\x80\x93635.</span> [<a href="/pubmed/7566175" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Protection+against+mycoplasma+infection+using+expression-library+immunization&amp;author=MA+Barry&amp;author=WC+Lai&amp;author=SA+Johnston&amp;volume=377&amp;issue=6550&amp;publication_year=1995&amp;pages=632-635&amp;pmid=7566175&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="citation">Piedrafita D, Xu D, Hunter D, Harrison RA, Liew FY. Protective immune responses induced by vaccination with an expression genomic library of <em>Leishmania major</em>\n. <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>1999;<span class="ref-vol">163</span>(3):1467\xe2\x80\x931472.</span> [<a href="/pubmed/10415048" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=Protective+immune+responses+induced+by+vaccination+with+an+expression+genomic+library+of+Leishmania+major&#10;&amp;author=D+Piedrafita&amp;author=D+Xu&amp;author=D+Hunter&amp;author=RA+Harrison&amp;author=FY+Liew&amp;volume=163&amp;issue=3&amp;publication_year=1999&amp;pages=1467-1472&amp;pmid=10415048&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="citation">Melby PC, Ogden GB, Flores HA, et al.  Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2000;<span class="ref-vol">68</span>(10):5595\xe2\x80\x935602.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC101511/">PMC free article</a>]</span> [<a href="/pubmed/10992459" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Identification+of+vaccine+candidates+for+experimental+visceral+leishmaniasis+by+immunization+with+sequential+fractions+of+a+cDNA+expression+library&amp;author=PC+Melby&amp;author=GB+Ogden&amp;author=HA+Flores&amp;volume=68&amp;issue=10&amp;publication_year=2000&amp;pages=5595-5602&amp;pmid=10992459&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49">49. <span class="citation">Ivens AC, Peacock CS, Worthey EA, et al.  The genome of the kinetoplastid parasite, <em>Leishmania major</em>\n. <span><span class="ref-journal"><em>Science</em>. </span>2005;<span class="ref-vol">309</span>(5733):436\xe2\x80\x93442.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1470643/">PMC free article</a>]</span> [<a href="/pubmed/16020728" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+genome+of+the+kinetoplastid+parasite,+Leishmania+major&#10;&amp;author=AC+Ivens&amp;author=CS+Peacock&amp;author=EA+Worthey&amp;volume=309&amp;issue=5733&amp;publication_year=2005&amp;pages=436-442&amp;pmid=16020728&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50">50. <span class="citation">Stober CB. From genomes to vaccines for leishmaniasis. <span><span class="ref-journal"><em>Methods in Molecular Biology</em>. </span>2004;<span class="ref-vol">270</span>:423\xe2\x80\x93438.</span> [<a href="/pubmed/15153643" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+in+Molecular+Biology&amp;title=From+genomes+to+vaccines+for+leishmaniasis&amp;author=CB+Stober&amp;volume=270&amp;publication_year=2004&amp;pages=423-438&amp;pmid=15153643&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B51">51. <span class="citation">Stober CB, Lange UG, Roberts MTM, et al.  From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine <em>Leishmania major</em> infection. <span><span class="ref-journal"><em>Vaccine</em>. </span>2006;<span class="ref-vol">24</span>(14):2602\xe2\x80\x932616.</span> [<a href="/pubmed/16406227" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=From+genome+to+vaccines+for+leishmaniasis:+screening+100+novel+vaccine+candidates+against+murine+Leishmania+major+infection&amp;author=CB+Stober&amp;author=UG+Lange&amp;author=MTM+Roberts&amp;volume=24&amp;issue=14&amp;publication_year=2006&amp;pages=2602-2616&amp;pmid=16406227&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B52">52. <span class="citation">Saravia NG, Hazb&#x000f3;n MH, Osorio Y, et al.  Protective immunogenicity of the paraflagellar rod protein 2 of <em>Leishmania mexicana</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>2005;<span class="ref-vol">23</span>(8):984\xe2\x80\x93995.</span> [<a href="/pubmed/15620471" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Protective+immunogenicity+of+the+paraflagellar+rod+protein+2+of+Leishmania+mexicana&#10;&amp;author=NG+Saravia&amp;author=MH+Hazb&#x000f3;n&amp;author=Y+Osorio&amp;volume=23&amp;issue=8&amp;publication_year=2005&amp;pages=984-995&amp;pmid=15620471&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B53">53. <span class="citation">Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of <em>Leishmania donovani</em> that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>2005;<span class="ref-vol">174</span>(11):7160\xe2\x80\x937171.</span> [<a href="/pubmed/15905560" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=Kinetoplastid+membrane+protein-11+DNA+vaccination+induces+complete+protection+against+both+pentavalent+antimonial-sensitive+and+-resistant+strains+of+Leishmania+donovani+that+correlates+with+inducible+nitric+oxide+synthase+activity+and+IL-4+generation:+evidence+for+mixed+Th1-+and+Th2-like+responses+in+visceral+leishmaniasis&amp;author=R+Basu&amp;author=S+Bhaumik&amp;author=JM+Basu&amp;author=K+Naskar&amp;author=T+De&amp;volume=174&amp;issue=11&amp;publication_year=2005&amp;pages=7160-7171&amp;pmid=15905560&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B54">54. <span class="citation">Fragaki K, Suffia I, Ferrua B, Rousseau D, Le Fichoux Y, Kubar J. Immunisation with DNA encoding <em>Leishmania infantum</em> protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters. <span><span class="ref-journal"><em>Vaccine</em>. </span>2001;<span class="ref-vol">19</span>(13-14):1701\xe2\x80\x931709.</span> [<a href="/pubmed/11166894" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immunisation+with+DNA+encoding+Leishmania+infantum+protein+papLe22+decreases+the+frequency+of+parasitemic+episodes+in+infected+hamsters&amp;author=K+Fragaki&amp;author=I+Suffia&amp;author=B+Ferrua&amp;author=D+Rousseau&amp;author=Y+Le+Fichoux&amp;volume=19&amp;issue=13-14&amp;publication_year=2001&amp;pages=1701-1709&amp;pmid=11166894&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B55">55. <span class="citation">Ramiro MJ, Z&#x000e1;rate JJ, Hanke T, et al.  Protection in dogs against visceral leishmaniasis caused by <em>Leishmania infantum</em> is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. <span><span class="ref-journal"><em>Vaccine</em>. </span>2003;<span class="ref-vol">21</span>(19-20):2474\xe2\x80\x932484.</span> [<a href="/pubmed/12744881" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Protection+in+dogs+against+visceral+leishmaniasis+caused+by+Leishmania+infantum+is+achieved+by+immunization+with+a+heterologous+prime-boost+regime+using+DNA+and+vaccinia+recombinant+vectors+expressing+LACK&amp;author=MJ+Ramiro&amp;author=JJ+Z&#x000e1;rate&amp;author=T+Hanke&amp;volume=21&amp;issue=19-20&amp;publication_year=2003&amp;pages=2474-2484&amp;pmid=12744881&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B56">56. <span class="citation">Saldarriaga OA, Travi BL, Park W, Perez LE, Melby PC. Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs. <span><span class="ref-journal"><em>Vaccine</em>. </span>2006;<span class="ref-vol">24</span>(11):1928\xe2\x80\x931940.</span> [<a href="/pubmed/16310897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immunogenicity+of+a+multicomponent+DNA+vaccine+against+visceral+leishmaniasis+in+dogs&amp;author=OA+Saldarriaga&amp;author=BL+Travi&amp;author=W+Park&amp;author=LE+Perez&amp;author=PC+Melby&amp;volume=24&amp;issue=11&amp;publication_year=2006&amp;pages=1928-1940&amp;pmid=16310897&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B57">57. <span class="citation">Rafati S, Nakhaee A, Taheri T, et al.  Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of <em>L. infantum</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>2005;<span class="ref-vol">23</span>(28):3716\xe2\x80\x933725.</span> [<a href="/pubmed/15882533" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Protective+vaccination+against+experimental+canine+visceral+leishmaniasis+using+a+combination+of+DNA+and+protein+immunization+with+cysteine+proteinases+type+I+and+II+of+L.+infantum&#10;&amp;author=S+Rafati&amp;author=A+Nakhaee&amp;author=T+Taheri&amp;volume=23&amp;issue=28&amp;publication_year=2005&amp;pages=3716-3725&amp;pmid=15882533&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B58">58. <span class="citation">Autran B, Carcelain G, Combadiere B, Debre P. Therapeutic vaccines for chronic infections. <span><span class="ref-journal"><em>Science</em>. </span>2004;<span class="ref-vol">305</span>(5681):205\xe2\x80\x93208.</span> [<a href="/pubmed/15247470" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Therapeutic+vaccines+for+chronic+infections&amp;author=B+Autran&amp;author=G+Carcelain&amp;author=B+Combadiere&amp;author=P+Debre&amp;volume=305&amp;issue=5681&amp;publication_year=2004&amp;pages=205-208&amp;pmid=15247470&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B59">59. <span class="citation">Handman E, Noormohammadi AH, Curtis JM, Baldwin T, Sj&#x000f6;lander A. Therapy of murine cutaneous leishmaniasis by DNA vaccination. <span><span class="ref-journal"><em>Vaccine</em>. </span>2000;<span class="ref-vol">18</span>(26):3011\xe2\x80\x933017.</span> [<a href="/pubmed/10825604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Therapy+of+murine+cutaneous+leishmaniasis+by+DNA+vaccination&amp;author=E+Handman&amp;author=AH+Noormohammadi&amp;author=JM+Curtis&amp;author=T+Baldwin&amp;author=A+Sj&#x000f6;lander&amp;volume=18&amp;issue=26&amp;publication_year=2000&amp;pages=3011-3017&amp;pmid=10825604&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B60">60. <span class="citation">Gamboa-Le&#x000f3;n R, Paraguai de Souza E, Borja-Cabrera GP, et al.  Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of <em>Leishmania donovani</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>2006;<span class="ref-vol">24</span>(22):4863\xe2\x80\x934873.</span> [<a href="/pubmed/16635538" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immunotherapy+against+visceral+leishmaniasis+with+the+nucleoside+hydrolase-DNA+vaccine+of+Leishmania+donovani&#10;&amp;author=R+Gamboa-Le&#x000f3;n&amp;author=E+Paraguai+de+Souza&amp;author=GP+Borja-Cabrera&amp;volume=24&amp;issue=22&amp;publication_year=2006&amp;pages=4863-4873&amp;pmid=16635538&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B61">61. <span class="citation">Espinoza JR, Skinner AC, Davies CR, et al.  Extensive polymorphism at the Gp63 locus in field isolates of <em>Leishmania peruviana</em>\n. <span><span class="ref-journal"><em>Molecular and Biochemical Parasitology</em>. </span>1995;<span class="ref-vol">72</span>(1-2):203\xe2\x80\x93213.</span> [<a href="/pubmed/8538690" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+and+Biochemical+Parasitology&amp;title=Extensive+polymorphism+at+the+Gp63+locus+in+field+isolates+of+Leishmania+peruviana&#10;&amp;author=JR+Espinoza&amp;author=AC+Skinner&amp;author=CR+Davies&amp;volume=72&amp;issue=1-2&amp;publication_year=1995&amp;pages=203-213&amp;pmid=8538690&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B62">62. <span class="citation">Guerbouj S, Victoir K, Guizani I, et al.  Gp63 gene polymorphism and population structure of <em>Leishmania donovani</em> complex: influence of the host selection pressure? <span><span class="ref-journal"><em>Parasitology</em>. </span>2001;<span class="ref-vol">122</span>(1):25\xe2\x80\x9335.</span> [<a href="/pubmed/11197761" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Parasitology&amp;title=Gp63+gene+polymorphism+and+population+structure+of+Leishmania+donovani+complex:+influence+of+the+host+selection+pressure?&amp;author=S+Guerbouj&amp;author=K+Victoir&amp;author=I+Guizani&amp;volume=122&amp;issue=1&amp;publication_year=2001&amp;pages=25-35&amp;pmid=11197761&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B63">63. <span class="citation">Alvarez-Valin F, Tort JF, Bernardi G. Nonrandom spatial distribution of synonymous substitutions in the GP63 gene from <em>Leishmania</em>\n. <span><span class="ref-journal"><em>Genetics</em>. </span>2000;<span class="ref-vol">155</span>(4):1683\xe2\x80\x931692.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1461213/">PMC free article</a>]</span> [<a href="/pubmed/10924466" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Nonrandom+spatial+distribution+of+synonymous+substitutions+in+the+GP63+gene+from+Leishmania&#10;&amp;author=F+Alvarez-Valin&amp;author=JF+Tort&amp;author=G+Bernardi&amp;volume=155&amp;issue=4&amp;publication_year=2000&amp;pages=1683-1692&amp;pmid=10924466&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B64">64. <span class="citation">Guerbouj S, Guizani I, Victoir K, Le Ray D, Dujardin J-C. Parasite candidate vaccines: a warning from polymorphic <em>Leishmania</em> populations. <span><span class="ref-journal"><em>Parasitology Today</em>. </span>2000;<span class="ref-vol">16</span>(6):265\xe2\x80\x93266.</span> [<a href="/pubmed/10827439" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Parasitology+Today&amp;title=Parasite+candidate+vaccines:+a+warning+from+polymorphic+Leishmania+populations&amp;author=S+Guerbouj&amp;author=I+Guizani&amp;author=K+Victoir&amp;author=D+Le+Ray&amp;author=J-C+Dujardin&amp;volume=16&amp;issue=6&amp;publication_year=2000&amp;pages=265-266&amp;pmid=10827439&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B65">65. <span class="citation">Fitzpatrick DA, Creevey CJ, McInerney JO. Evidence of positive Darwinian selection in putative meningococcal vaccine antigens. <span><span class="ref-journal"><em>Journal of Molecular Evolution</em>. </span>2005;<span class="ref-vol">61</span>(1):90\xe2\x80\x9398.</span> [<a href="/pubmed/16007491" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Molecular+Evolution&amp;title=Evidence+of+positive+Darwinian+selection+in+putative+meningococcal+vaccine+antigens&amp;author=DA+Fitzpatrick&amp;author=CJ+Creevey&amp;author=JO+McInerney&amp;volume=61&amp;issue=1&amp;publication_year=2005&amp;pages=90-98&amp;pmid=16007491&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B66">66. <span class="citation">Kumkhaek C, Phra-Ek K, R&#x000e9;nia L, et al.  Are extensive T cell epitope polymorphisms in the <em>Plasmodium falciparum</em> circumsporozoite antigen, a leading sporozoite vaccine candidate, selected by immune pressure? <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>2005;<span class="ref-vol">175</span>(6):3935\xe2\x80\x933939.</span> [<a href="/pubmed/16148140" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=Are+extensive+T+cell+epitope+polymorphisms+in+the+Plasmodium+falciparum+circumsporozoite+antigen,+a+leading+sporozoite+vaccine+candidate,+selected+by+immune+pressure?&amp;author=C+Kumkhaek&amp;author=K+Phra-Ek&amp;author=L+R&#x000e9;nia&amp;volume=175&amp;issue=6&amp;publication_year=2005&amp;pages=3935-3939&amp;pmid=16148140&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B67">67. <span class="citation">Pinto EF, Pinheiro RO, Rayol A, Larraga V, Rossi-Bergmann B. Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2004;<span class="ref-vol">72</span>(8):4521\xe2\x80\x934527.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC470668/">PMC free article</a>]</span> [<a href="/pubmed/15271911" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Intranasal+vaccination+against+cutaneous+leishmaniasis+with+a+particulated+leishmanial+antigen+or+DNA+encoding+LACK&amp;author=EF+Pinto&amp;author=RO+Pinheiro&amp;author=A+Rayol&amp;author=V+Larraga&amp;author=B+Rossi-Bergmann&amp;volume=72&amp;issue=8&amp;publication_year=2004&amp;pages=4521-4527&amp;pmid=15271911&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B68">68. <span class="citation">Belkaid Y, Kamhawi S, Modi G, et al.  Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of <em>Leishmania major</em> infection in the mouse ear dermis. <span><span class="ref-journal"><em>The Journal of Experimental Medicine</em>. </span>1998;<span class="ref-vol">188</span>(10):1941\xe2\x80\x931953.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2212417/">PMC free article</a>]</span> [<a href="/pubmed/9815271" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Experimental+Medicine&amp;title=Development+of+a+natural+model+of+cutaneous+leishmaniasis:+powerful+effects+of+vector+saliva+and+saliva+preexposure+on+the+long-term+outcome+of+Leishmania+major+infection+in+the+mouse+ear+dermis&amp;author=Y+Belkaid&amp;author=S+Kamhawi&amp;author=G+Modi&amp;volume=188&amp;issue=10&amp;publication_year=1998&amp;pages=1941-1953&amp;pmid=9815271&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B69">69. <span class="citation">Mbow ML, Bleyenberg JA, Hall LR, Titus RG. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with <em>Leishmania major</em>\n. <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>1998;<span class="ref-vol">161</span>(10):5571\xe2\x80\x935577.</span> [<a href="/pubmed/9820534" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=Phlebotomus+papatasi+sand+fly+salivary+gland+lysate+down-regulates+a+Th1,+but+up-regulates+a+Th2,+response+in+mice+infected+with+Leishmania+major&#10;&amp;author=ML+Mbow&amp;author=JA+Bleyenberg&amp;author=LR+Hall&amp;author=RG+Titus&amp;volume=161&amp;issue=10&amp;publication_year=1998&amp;pages=5571-5577&amp;pmid=9820534&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B70">70. <span class="citation">Kamhawi S, Belkaid Y, Modi G, Rowton E, Sacks D. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. <span><span class="ref-journal"><em>Science</em>. </span>2000;<span class="ref-vol">290</span>(5495):1351\xe2\x80\x931354.</span> [<a href="/pubmed/11082061" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Protection+against+cutaneous+leishmaniasis+resulting+from+bites+of+uninfected+sand+flies&amp;author=S+Kamhawi&amp;author=Y+Belkaid&amp;author=G+Modi&amp;author=E+Rowton&amp;author=D+Sacks&amp;volume=290&amp;issue=5495&amp;publication_year=2000&amp;pages=1351-1354&amp;pmid=11082061&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B71">71. <span class="citation">Morris RV, Shoemaker CB, David JR, Lanzaro GC, Titus RG. Sandfly maxadilan exacerbates infection with <em>Leishmania major</em> and vaccinating against it protects against <em>L. major</em> infection. <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>2001;<span class="ref-vol">167</span>(9):5226\xe2\x80\x935230.</span> [<a href="/pubmed/11673536" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=Sandfly+maxadilan+exacerbates+infection+with+Leishmania+major+and+vaccinating+against+it+protects+against+L.+major+infection&amp;author=RV+Morris&amp;author=CB+Shoemaker&amp;author=JR+David&amp;author=GC+Lanzaro&amp;author=RG+Titus&amp;volume=167&amp;issue=9&amp;publication_year=2001&amp;pages=5226-5230&amp;pmid=11673536&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B72">72. <span class="citation">Valenzuela JG, Belkaid Y, Garfield MK, et al.  Toward a defined anti-<em>Leishmania</em> vaccine targeting vector antigens: characterization of a protective salivary protein. <span><span class="ref-journal"><em>The Journal of Experimental Medicine</em>. </span>2001;<span class="ref-vol">194</span>(3):331\xe2\x80\x93342.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2193460/">PMC free article</a>]</span> [<a href="/pubmed/11489952" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Experimental+Medicine&amp;title=Toward+a+defined+anti-Leishmania+vaccine+targeting+vector+antigens:+characterization+of+a+protective+salivary+protein&amp;author=JG+Valenzuela&amp;author=Y+Belkaid&amp;author=MK+Garfield&amp;volume=194&amp;issue=3&amp;publication_year=2001&amp;pages=331-342&amp;pmid=11489952&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B73">73. <span class="citation">Anderson JM, Oliveira F, Kamhawi S, et al.  Comparative salivary gland transcriptomics of sandfly vectors of visceral leishmaniasis. <span><span class="ref-journal"><em>BMC Genomics</em>. </span>2006;<span class="ref-vol">7</span>:52.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1434747/">PMC free article</a>]</span> [<a href="/pubmed/16539713" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Genomics&amp;title=Comparative+salivary+gland+transcriptomics+of+sandfly+vectors+of+visceral+leishmaniasis&amp;author=JM+Anderson&amp;author=F+Oliveira&amp;author=S+Kamhawi&amp;volume=7&amp;publication_year=2006&amp;pages=52&amp;pmid=16539713&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B74">74. <span class="citation">Valenzuela JG, Garfield M, Rowton ED, Pham VM. Identification of the most abundant secreted proteins from the salivary glands of the sand fly <em>Lutzomyia longipalpis</em>, vector of <em>Leishmania chagasi</em>\n. <span><span class="ref-journal"><em>The Journal of Experimental Biology</em>. </span>2004;<span class="ref-vol">207</span>(21):3717\xe2\x80\x933729.</span> [<a href="/pubmed/15371479" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Experimental+Biology&amp;title=Identification+of+the+most+abundant+secreted+proteins+from+the+salivary+glands+of+the+sand+fly+Lutzomyia+longipalpis,+vector+of+Leishmania+chagasi&#10;&amp;author=JG+Valenzuela&amp;author=M+Garfield&amp;author=ED+Rowton&amp;author=VM+Pham&amp;volume=207&amp;issue=21&amp;publication_year=2004&amp;pages=3717-3729&amp;pmid=15371479&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B75">75. <span class="citation">Elnaiem D-EA, Meneses C, Slotman M, Lanzaro GC. Genetic variation in the sand fly salivary protein, SP-15, a potential vaccine candidate against <em>Leishmania major</em>\n. <span><span class="ref-journal"><em>Insect Molecular Biology</em>. </span>2005;<span class="ref-vol">14</span>(2):145\xe2\x80\x93150.</span> [<a href="/pubmed/15796747" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Insect+Molecular+Biology&amp;title=Genetic+variation+in+the+sand+fly+salivary+protein,+SP-15,+a+potential+vaccine+candidate+against+Leishmania+major&#10;&amp;author=D-EA+Elnaiem&amp;author=C+Meneses&amp;author=M+Slotman&amp;author=GC+Lanzaro&amp;volume=14&amp;issue=2&amp;publication_year=2005&amp;pages=145-150&amp;pmid=15796747&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B76">76. <span class="citation">Milleron RS, Mutebi J-P, Valle S, et al.  Antigenic diversity in maxadilan, a salivary protein from the sand fly vector of American visceral leishmaniasis. <span><span class="ref-journal"><em>American Journal of Tropical Medicine and Hygiene</em>. </span>2004;<span class="ref-vol">70</span>(3):286\xe2\x80\x93293.</span> [<a href="/pubmed/15031518" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Tropical+Medicine+and+Hygiene&amp;title=Antigenic+diversity+in+maxadilan,+a+salivary+protein+from+the+sand+fly+vector+of+American+visceral+leishmaniasis&amp;author=RS+Milleron&amp;author=J-P+Mutebi&amp;author=S+Valle&amp;volume=70&amp;issue=3&amp;publication_year=2004&amp;pages=286-293&amp;pmid=15031518&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B77">77. <span class="citation">Saraiva EM, de Figueiredo Barbosa A, Santos FN, et al.  The FML-vaccine (Leishmune<sup>&#x000ae;</sup>) against canine visceral leishmaniasis: a transmission blocking vaccine. <span><span class="ref-journal"><em>Vaccine</em>. </span>2006;<span class="ref-vol">24</span>(13):2423\xe2\x80\x932431.</span> [<a href="/pubmed/16386824" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=The+FML-vaccine+(Leishmune&#x000ae;)+against+canine+visceral+leishmaniasis:+a+transmission+blocking+vaccine&amp;author=EM+Saraiva&amp;author=A+de+Figueiredo+Barbosa&amp;author=FN+Santos&amp;volume=24&amp;issue=13&amp;publication_year=2006&amp;pages=2423-2431&amp;pmid=16386824&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B78">78. <span class="citation">Giron&#x000e9;s N, Cuervo H, Fresno M. \n<em>Trypanosoma cruzi</em>-induced molecular mimicry and Chagas\' disease. <span><span class="ref-journal"><em>Current Topics in Microbiology and Immunology</em>. </span>2005;<span class="ref-vol">296</span>:89\xe2\x80\x93123.</span> [<a href="/pubmed/16323421" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Topics+in+Microbiology+and+Immunology&amp;title=&#10;Trypanosoma+cruzi-induced+molecular+mimicry+and+Chagas\'+disease&amp;author=N+Giron&#x000e9;s&amp;author=H+Cuervo&amp;author=M+Fresno&amp;volume=296&amp;publication_year=2005&amp;pages=89-123&amp;pmid=16323421&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B79">79. <span class="citation">Tarleton RL. Parasite persistence in the aetiology of Chagas disease. <span><span class="ref-journal"><em>International Journal for Parasitology</em>. </span>2001;<span class="ref-vol">31</span>(5-6):549\xe2\x80\x93553.</span> [<a href="/pubmed/11334941" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+Journal+for+Parasitology&amp;title=Parasite+persistence+in+the+aetiology+of+Chagas+disease&amp;author=RL+Tarleton&amp;volume=31&amp;issue=5-6&amp;publication_year=2001&amp;pages=549-553&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B80">80. <span class="citation">Bhatia V, Garg N. Current status and future prospects for a vaccine against American trypanosomiasis. <span><span class="ref-journal"><em>Expert Review of Vaccines</em>. </span>2005;<span class="ref-vol">4</span>(6):867\xe2\x80\x93880.</span> [<a href="/pubmed/16372882" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Review+of+Vaccines&amp;title=Current+status+and+future+prospects+for+a+vaccine+against+American+trypanosomiasis&amp;author=V+Bhatia&amp;author=N+Garg&amp;volume=4&amp;issue=6&amp;publication_year=2005&amp;pages=867-880&amp;pmid=16372882&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B81">81. <span class="citation">Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease? <span><span class="ref-journal"><em>Trends in Parasitology</em>. </span>2005;<span class="ref-vol">21</span>(11):513\xe2\x80\x93516.</span> [<a href="/pubmed/16125464" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+in+Parasitology&amp;title=Where+do+we+stand+on+the+autoimmunity+hypothesis+of+Chagas+disease?&amp;author=F+Kierszenbaum&amp;volume=21&amp;issue=11&amp;publication_year=2005&amp;pages=513-516&amp;pmid=16125464&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B82">82. <span class="citation">Hoft DF, Schnapp AR, Eickhoff CS, Roodman ST. Involvement of CD4<sup>+</sup> Th1 cells in systemic immunity protective against primary and secondary challenges with <em>Trypanosoma cruzi</em>\n. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2000;<span class="ref-vol">68</span>(1):197\xe2\x80\x93204.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC97121/">PMC free article</a>]</span> [<a href="/pubmed/10603388" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Involvement+of+CD4++Th1+cells+in+systemic+immunity+protective+against+primary+and+secondary+challenges+with+Trypanosoma+cruzi&#10;&amp;author=DF+Hoft&amp;author=AR+Schnapp&amp;author=CS+Eickhoff&amp;author=ST+Roodman&amp;volume=68&amp;issue=1&amp;publication_year=2000&amp;pages=197-204&amp;pmid=10603388&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B83">83. <span class="citation">Martin D, Tarleton R. Generation, specificity, and function of CD8<sup>+</sup> T cells in <em>Trypanosoma cruzi</em> infection. <span><span class="ref-journal"><em>Immunological Reviews</em>. </span>2004;<span class="ref-vol">201</span>(1):304\xe2\x80\x93317.</span> [<a href="/pubmed/15361249" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunological+Reviews&amp;title=Generation,+specificity,+and+function+of+CD8++T+cells+in+Trypanosoma+cruzi+infection&amp;author=D+Martin&amp;author=R+Tarleton&amp;volume=201&amp;issue=1&amp;publication_year=2004&amp;pages=304-317&amp;pmid=15361249&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B84">84. <span class="citation">Rodrigues MM, Ribeir&#x000e3;o M, Pereira-Chioccola V, Renia L, Costa F. Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a <em>Trypanosoma cruzi</em> gene. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>1999;<span class="ref-vol">67</span>(8):3855\xe2\x80\x933863.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC96665/">PMC free article</a>]</span> [<a href="/pubmed/10417149" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Predominance+of+CD4+Th1+and+CD8+Tc1+cells+revealed+by+characterization+of+the+cellular+immune+response+generated+by+immunization+with+a+DNA+vaccine+containing+a+Trypanosoma+cruzi+gene&amp;author=MM+Rodrigues&amp;author=M+Ribeir&#x000e3;o&amp;author=V+Pereira-Chioccola&amp;author=L+Renia&amp;author=F+Costa&amp;volume=67&amp;issue=8&amp;publication_year=1999&amp;pages=3855-3863&amp;pmid=10417149&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B85">85. <span class="citation">Rodrigues MM, Boscardin SB, Vasconcelos JR, Hiyane MI, Salay G, Soares IS. Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines. <span><span class="ref-journal"><em>Anais da Academia Brasileira de Ci&#x000ea;ncias</em>. </span>2003;<span class="ref-vol">75</span>(4):443\xe2\x80\x93468.</span> [<a href="/pubmed/14605680" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anais+da+Academia+Brasileira+de+Ci&#x000ea;ncias&amp;title=Importance+of+CD8+T+cell-mediated+immune+response+during+intracellular+parasitic+infections+and+its+implications+for+the+development+of+effective+vaccines&amp;author=MM+Rodrigues&amp;author=SB+Boscardin&amp;author=JR+Vasconcelos&amp;author=MI+Hiyane&amp;author=G+Salay&amp;volume=75&amp;issue=4&amp;publication_year=2003&amp;pages=443-468&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B86">86. <span class="citation">Costa F, Franchin G, Pereira-Chioccola VL, Ribeir&#x000e3;o M, Schenkman S, Rodrigues MM. Immunization with a plasmid DNA containing the gene of <em>trans</em>-sialidase reduces <em>Trypanosoma cruzi</em> infection in mice. <span><span class="ref-journal"><em>Vaccine</em>. </span>1998;<span class="ref-vol">16</span>(8):768\xe2\x80\x93774.</span> [<a href="/pubmed/9627933" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immunization+with+a+plasmid+DNA+containing+the+gene+of+trans-sialidase+reduces+Trypanosoma+cruzi+infection+in+mice&amp;author=F+Costa&amp;author=G+Franchin&amp;author=VL+Pereira-Chioccola&amp;author=M+Ribeir&#x000e3;o&amp;author=S+Schenkman&amp;volume=16&amp;issue=8&amp;publication_year=1998&amp;pages=768-774&amp;pmid=9627933&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B87">87. <span class="citation">Garg N, Tarleton RL. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in <em>Trypanosoma cruzi</em> infection. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2002;<span class="ref-vol">70</span>(10):5547\xe2\x80\x935555.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC128309/">PMC free article</a>]</span> [<a href="/pubmed/12228281" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Genetic+immunization+elicits+antigen-specific+protective+immune+responses+and+decreases+disease+severity+in+Trypanosoma+cruzi+infection&amp;author=N+Garg&amp;author=RL+Tarleton&amp;volume=70&amp;issue=10&amp;publication_year=2002&amp;pages=5547-5555&amp;pmid=12228281&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B88">88. <span class="citation">Wizel B, Nunes M, Tarleton RL. Identification of <em>Trypanosoma cruzi</em> trans-sialidase family members as targets of protective CD8<sup>+</sup> TC1 responses. <span><span class="ref-journal"><em>The Journal of Immunology</em>. </span>1997;<span class="ref-vol">159</span>(12):6120\xe2\x80\x936130.</span> [<a href="/pubmed/9550413" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Immunology&amp;title=Identification+of+Trypanosoma+cruzi+trans-sialidase+family+members+as+targets+of+protective+CD8++TC1+responses&amp;author=B+Wizel&amp;author=M+Nunes&amp;author=RL+Tarleton&amp;volume=159&amp;issue=12&amp;publication_year=1997&amp;pages=6120-6130&amp;pmid=9550413&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B89">89. <span class="citation">Costa F, Pereira-Chioccola VL, Ribeir&#x000e3;o M, Schenkman S, Rodrigues MM. \n<em>Trans</em>-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a <em>Trypanosoma cruzi</em> infection. <span><span class="ref-journal"><em>Brazilian Journal of Medical and Biological Research</em>. </span>1999;<span class="ref-vol">32</span>(2):235\xe2\x80\x93239.</span> [<a href="/pubmed/10347760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brazilian+Journal+of+Medical+and+Biological+Research&amp;title=&#10;Trans-sialidase+delivered+as+a+naked+DNA+vaccine+elicits+an+immunological+response+similar+to+a+Trypanosoma+cruzi+infection&amp;author=F+Costa&amp;author=VL+Pereira-Chioccola&amp;author=M+Ribeir&#x000e3;o&amp;author=S+Schenkman&amp;author=MM+Rodrigues&amp;volume=32&amp;issue=2&amp;publication_year=1999&amp;pages=235-239&amp;pmid=10347760&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B90">90. <span class="citation">Pereira-Chioccola VL, Costa F, Ribeir&#x000e3;o M, et al.  Comparison of antibody and protective immune responses against <em>Trypanosoma cruzi</em> infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein. <span><span class="ref-journal"><em>Parasite Immunology</em>. </span>1999;<span class="ref-vol">21</span>(2):103\xe2\x80\x93110.</span> [<a href="/pubmed/10101720" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Parasite+Immunology&amp;title=Comparison+of+antibody+and+protective+immune+responses+against+Trypanosoma+cruzi+infection+elicited+by+immunization+with+a+parasite+antigen+delivered+as+naked+DNA+or+recombinant+protein&amp;author=VL+Pereira-Chioccola&amp;author=F+Costa&amp;author=M+Ribeir&#x000e3;o&amp;volume=21&amp;issue=2&amp;publication_year=1999&amp;pages=103-110&amp;pmid=10101720&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B91">91. <span class="citation">Wizel B, Garg N, Tarleton RL. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal <em>Trypanosoma cruzi</em> infection. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>1998;<span class="ref-vol">66</span>(11):5073\xe2\x80\x935081.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC108632/">PMC free article</a>]</span> [<a href="/pubmed/9784506" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Vaccination+with+trypomastigote+surface+antigen+1-encoding+plasmid+DNA+confers+protection+against+lethal+Trypanosoma+cruzi+infection&amp;author=B+Wizel&amp;author=N+Garg&amp;author=RL+Tarleton&amp;volume=66&amp;issue=11&amp;publication_year=1998&amp;pages=5073-5081&amp;pmid=9784506&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B92">92. <span class="citation">Garc&#x000ed;a GA, Arnaiz MR, Laucella SA, et al.  Immunological and pathological responses in BALB/c mice induced by genetic administration of <em>Tc</em>13 Tul antigen of <em>Trypanosoma cruzi</em>\n. <span><span class="ref-journal"><em>Parasitology</em>. </span>2006;<span class="ref-vol">132</span>(6):855\xe2\x80\x93866.</span> [<a href="/pubmed/16478565" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Parasitology&amp;title=Immunological+and+pathological+responses+in+BALB/c+mice+induced+by+genetic+administration+of+Tc13+Tul+antigen+of+Trypanosoma+cruzi&#10;&amp;author=GA+Garc&#x000ed;a&amp;author=MR+Arnaiz&amp;author=SA+Laucella&amp;volume=132&amp;issue=6&amp;publication_year=2006&amp;pages=855-866&amp;pmid=16478565&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B93">93. <span class="citation">Boscardin SB, Kinoshita SS, Fujimura AE, Rodrigues MM. Immunization with cDNA expressed by amastigotes of <em>Trypanosoma cruzi</em> elicits protective immune response against experimental infection. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2003;<span class="ref-vol">71</span>(5):2744\xe2\x80\x932757.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC153249/">PMC free article</a>]</span> [<a href="/pubmed/12704149" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Immunization+with+cDNA+expressed+by+amastigotes+of+Trypanosoma+cruzi+elicits+protective+immune+response+against+experimental+infection&amp;author=SB+Boscardin&amp;author=SS+Kinoshita&amp;author=AE+Fujimura&amp;author=MM+Rodrigues&amp;volume=71&amp;issue=5&amp;publication_year=2003&amp;pages=2744-2757&amp;pmid=12704149&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B94">94. <span class="citation">Katae M, Miyahira Y, Takeda K, et al.  Coadministration of an interleukin-12 gene and a <em>Trypanosoma cruzi</em> gene improves vaccine efficacy. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2002;<span class="ref-vol">70</span>(9):4833\xe2\x80\x934840.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC128276/">PMC free article</a>]</span> [<a href="/pubmed/12183527" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Coadministration+of+an+interleukin-12+gene+and+a+Trypanosoma+cruzi+gene+improves+vaccine+efficacy&amp;author=M+Katae&amp;author=Y+Miyahira&amp;author=K+Takeda&amp;volume=70&amp;issue=9&amp;publication_year=2002&amp;pages=4833-4840&amp;pmid=12183527&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B95">95. <span class="citation">Miyahira Y, Katae M, Takeda K, et al.  Activation of natural killer T cells by <em>&#x003b1;</em>-galactosylceramide impairs DNA vaccine-induced protective immunity against <em>Trypanosoma cruzi</em>\n. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2003;<span class="ref-vol">71</span>(3):1234\xe2\x80\x931241.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC148846/">PMC free article</a>]</span> [<a href="/pubmed/12595437" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Activation+of+natural+killer+T+cells+by+&#x003b1;-galactosylceramide+impairs+DNA+vaccine-induced+protective+immunity+against+Trypanosoma+cruzi&#10;&amp;author=Y+Miyahira&amp;author=M+Katae&amp;author=K+Takeda&amp;volume=71&amp;issue=3&amp;publication_year=2003&amp;pages=1234-1241&amp;pmid=12595437&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B96">96. <span class="citation">Fralish BH, Tarleton RL. Genetic immunization with <em>LYT1</em> or a pool of <em>trans</em>-sialidase genes protects mice from lethal <em>Trypanosoma cruzi</em> infection. <span><span class="ref-journal"><em>Vaccine</em>. </span>2003;<span class="ref-vol">21</span>(21-22):3070\xe2\x80\x933080.</span> [<a href="/pubmed/12798651" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Genetic+immunization+with+LYT1+or+a+pool+of+trans-sialidase+genes+protects+mice+from+lethal+Trypanosoma+cruzi+infection&amp;author=BH+Fralish&amp;author=RL+Tarleton&amp;volume=21&amp;issue=21-22&amp;publication_year=2003&amp;pages=3070-3080&amp;pmid=12798651&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B97">97. <span class="citation">Vasconcelos JR, Hiyane MI, Marinho CRF, et al.  Protective immunity against <em>Trypanosoma cruzi</em> infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. <span><span class="ref-journal"><em>Human Gene Therapy</em>. </span>2004;<span class="ref-vol">15</span>(9):878\xe2\x80\x93886.</span> [<a href="/pubmed/15353042" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Gene+Therapy&amp;title=Protective+immunity+against+Trypanosoma+cruzi+infection+in+a+highly+susceptible+mouse+strain+after+vaccination+with+genes+encoding+the+amastigote+surface+protein-2+and+trans-sialidase&amp;author=JR+Vasconcelos&amp;author=MI+Hiyane&amp;author=CRF+Marinho&amp;volume=15&amp;issue=9&amp;publication_year=2004&amp;pages=878-886&amp;pmid=15353042&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B98">98. <span class="citation">Sepulveda P, Hontebeyrie M, Liegeard P, Mascilli A, Norris KA. DNA-based immunization with <em>Trypanosoma cruzi</em> complement regulatory protein elicits complement lytic antibodies and confers protection against <em>Trypanosoma cruzi</em> infection. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2000;<span class="ref-vol">68</span>(9):4986\xe2\x80\x934991.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC101717/">PMC free article</a>]</span> [<a href="/pubmed/10948115" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=DNA-based+immunization+with+Trypanosoma+cruzi+complement+regulatory+protein+elicits+complement+lytic+antibodies+and+confers+protection+against+Trypanosoma+cruzi+infection&amp;author=P+Sepulveda&amp;author=M+Hontebeyrie&amp;author=P+Liegeard&amp;author=A+Mascilli&amp;author=KA+Norris&amp;volume=68&amp;issue=9&amp;publication_year=2000&amp;pages=4986-4991&amp;pmid=10948115&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B99">99\n. <span class="citation">Schnapp AR, Eickhoff CS, Scharfstein J, Hoft DF. Induction of B- and T-cell responses to cruzipain in the murine model of <em>Trypanosoma cruzi</em> infection. <span><span class="ref-journal"><em>Microbes and Infection</em>. </span>2002;<span class="ref-vol">4</span>(8):805\xe2\x80\x93813.</span> [<a href="/pubmed/12270727" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbes+and+Infection&amp;title=Induction+of+B-+and+T-cell+responses+to+cruzipain+in+the+murine+model+of+Trypanosoma+cruzi+infection&amp;author=AR+Schnapp&amp;author=CS+Eickhoff&amp;author=J+Scharfstein&amp;author=DF+Hoft&amp;volume=4&amp;issue=8&amp;publication_year=2002&amp;pages=805-813&amp;pmid=12270727&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B100">100. <span class="citation">Planelles L, Thomas MC, Alonso C, L&#x000f3;pez MC. DNA immunization with <em>Trypanosoma cruzi</em> HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2001;<span class="ref-vol">69</span>(10):6558\xe2\x80\x936563.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC98798/">PMC free article</a>]</span> [<a href="/pubmed/11553607" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=DNA+immunization+with+Trypanosoma+cruzi+HSP70+fused+to+the+KMP11+protein+elicits+a+cytotoxic+and+humoral+immune+response+against+the+antigen+and+leads+to+protection&amp;author=L+Planelles&amp;author=MC+Thomas&amp;author=C+Alonso&amp;author=MC+L&#x000f3;pez&amp;volume=69&amp;issue=10&amp;publication_year=2001&amp;pages=6558-6563&amp;pmid=11553607&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B101">101. <span class="citation">Tzelepis F, de Alencar BCG, Penido MLO, Gazzinelli RT, Persechini PM, Rodrigues MM. Distinct kinetics of effector CD8<sup>+</sup> cytotoxic T cells after infection with <em>Trypanosoma cruzi</em> in na&#x000ef;ve or vaccinated mice. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2006;<span class="ref-vol">74</span>(4):2477\xe2\x80\x932481.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1418894/">PMC free article</a>]</span> [<a href="/pubmed/16552083" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Distinct+kinetics+of+effector+CD8++cytotoxic+T+cells+after+infection+with+Trypanosoma+cruzi+in+na&#x000ef;ve+or+vaccinated+mice&amp;author=F+Tzelepis&amp;author=BCG+de+Alencar&amp;author=MLO+Penido&amp;author=RT+Gazzinelli&amp;author=PM+Persechini&amp;volume=74&amp;issue=4&amp;publication_year=2006&amp;pages=2477-2481&amp;pmid=16552083&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B102">102. <span class="citation">Fujimura AE, Kinoshita SS, Pereira-Chioccola VL, Rodrigues MM. DNA sequences encoding CD4<sup>+</sup> and CD8<sup>+</sup> T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a <em>Trypanosoma cruzi</em> gene. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2001;<span class="ref-vol">69</span>(9):5477\xe2\x80\x935486.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC98660/">PMC free article</a>]</span> [<a href="/pubmed/11500420" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=DNA+sequences+encoding+CD4++and+CD8++T-cell+epitopes+are+important+for+efficient+protective+immunity+induced+by+DNA+vaccination+with+a+Trypanosoma+cruzi+gene&amp;author=AE+Fujimura&amp;author=SS+Kinoshita&amp;author=VL+Pereira-Chioccola&amp;author=MM+Rodrigues&amp;volume=69&amp;issue=9&amp;publication_year=2001&amp;pages=5477-5486&amp;pmid=11500420&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B103">103. <span class="citation">Vasconcelos JR, Boscardin SB, Hiyane MI, Kinoshita SS, Fujimura AE, Rodrigues MM. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to <em>Trypanosoma cruzi</em> infection in a highly susceptible mouse strain. <span><span class="ref-journal"><em>Immunology and Cell Biology</em>. </span>2003;<span class="ref-vol">81</span>(2):121\xe2\x80\x93129.</span> [<a href="/pubmed/12631235" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunology+and+Cell+Biology&amp;title=A+DNA-priming+protein-boosting+regimen+significantly+improves+type+1+immune+response+but+not+protective+immunity+to+Trypanosoma+cruzi+infection+in+a+highly+susceptible+mouse+strain&amp;author=JR+Vasconcelos&amp;author=SB+Boscardin&amp;author=MI+Hiyane&amp;author=SS+Kinoshita&amp;author=AE+Fujimura&amp;volume=81&amp;issue=2&amp;publication_year=2003&amp;pages=121-129&amp;pmid=12631235&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B104">104. <span class="citation">Dumonteil E, Escobedo-Ortegon J, Reyes-Rodriguez N, Arjona-Torres A, Ramirez-Sierra MJ. Immunotherapy of <em>Trypanosoma cruzi</em> infection with DNA vaccines in mice. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2004;<span class="ref-vol">72</span>(1):46\xe2\x80\x9353.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC343959/">PMC free article</a>]</span> [<a href="/pubmed/14688079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Immunotherapy+of+Trypanosoma+cruzi+infection+with+DNA+vaccines+in+mice&amp;author=E+Dumonteil&amp;author=J+Escobedo-Ortegon&amp;author=N+Reyes-Rodriguez&amp;author=A+Arjona-Torres&amp;author=MJ+Ramirez-Sierra&amp;volume=72&amp;issue=1&amp;publication_year=2004&amp;pages=46-53&amp;pmid=14688079&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B105">105. <span class="citation">Sanchez-Burgos G, Mezquita-Vega G, Escobedo-Ortegon J, et al.  Comparative efficacy of DNA vaccines encoding various <em>Trypanosoma cruzi</em> antigens. <span></span> <em>FEMS Immunology and Medical Microbiology</em>,(Online Early Articles) Doi:10.1111/j.1574-695X.2007.00251.X, 2007. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Sanchez-Burgos+G+Mezquita-Vega+G+Escobedo-Ortegon+J+Comparative+efficacy+of+DNA+vaccines+encoding+various++Trypanosoma+cruzi++antigens+FEMS+Immunology+and+Medical+Microbiology+,(Online+Early+Articles)+Doi:10.1111/j.1574-695X.2007.00251.X,+2007.+" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B106">106. <span class="citation">Zapata-Estrella H, Hummel-Newell C, Sanchez-Burgos G, et al.  Control of <em>Trypanosoma cruzi</em> infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice. <span><span class="ref-journal"><em>Immunology Letters</em>. </span>2006;<span class="ref-vol">103</span>(2):186\xe2\x80\x93191.</span> [<a href="/pubmed/16378645" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunology+Letters&amp;title=Control+of+Trypanosoma+cruzi+infection+and+changes+in+T-cell+populations+induced+by+a+therapeutic+DNA+vaccine+in+mice&amp;author=H+Zapata-Estrella&amp;author=C+Hummel-Newell&amp;author=G+Sanchez-Burgos&amp;volume=103&amp;issue=2&amp;publication_year=2006&amp;pages=186-191&amp;pmid=16378645&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B107">107. <span class="citation">Alberti E, Acosta A, Sarmiento ME, et al.  Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library of <em>Trypanosoma cruzi</em>\n. <span><span class="ref-journal"><em>Vaccine</em>. </span>1998;<span class="ref-vol">16</span>(6):608\xe2\x80\x93612.</span> [<a href="/pubmed/9569472" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Specific+cellular+and+humoral+immune+response+in+Balb/c+mice+immunised+with+an+expression+genomic+library+of+Trypanosoma+cruzi&#10;&amp;author=E+Alberti&amp;author=A+Acosta&amp;author=ME+Sarmiento&amp;volume=16&amp;issue=6&amp;publication_year=1998&amp;pages=608-612&amp;pmid=9569472&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B108">108. <span class="citation">Bhatia V, Sinha M, Luxon B, Garg N. Utility of the <em>Trypanosoma cruzi</em> sequence database for identification of potential vaccine candidates by in silico and in vitro screening. <span><span class="ref-journal"><em>Infection and Immunity</em>. </span>2004;<span class="ref-vol">72</span>(11):6245\xe2\x80\x936254.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC523045/">PMC free article</a>]</span> [<a href="/pubmed/15501750" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Utility+of+the+Trypanosoma+cruzi+sequence+database+for+identification+of+potential+vaccine+candidates+by+in+silico+and+in+vitro+screening&amp;author=V+Bhatia&amp;author=M+Sinha&amp;author=B+Luxon&amp;author=N+Garg&amp;volume=72&amp;issue=11&amp;publication_year=2004&amp;pages=6245-6254&amp;pmid=15501750&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B109">109. <span class="citation">Manoj S, Babiuk LA, van Drunen Littel-van den Hurk S. Approaches to enhance the efficacy of DNA vaccines. <span><span class="ref-journal"><em>Critical Reviews in Clinical Laboratory Sciences</em>. </span>2004;<span class="ref-vol">41</span>(1):1\xe2\x80\x9339.</span> [<a href="/pubmed/15077722" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Critical+Reviews+in+Clinical+Laboratory+Sciences&amp;title=Approaches+to+enhance+the+efficacy+of+DNA+vaccines&amp;author=S+Manoj&amp;author=LA+Babiuk&amp;author=S+van+Drunen+Littel-van+den+Hurk&amp;volume=41&amp;issue=1&amp;publication_year=2004&amp;pages=1-39&amp;pmid=15077722&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B110">110. <span class="citation">Moutaftsi M, Peters B, Pasquetto V, et al.  A consensus epitope prediction approach identifies the breadth of murine T<sub>CD8+</sub>-cell responses to vaccinia virus. <span><span class="ref-journal"><em>Nature Biotechnology</em>. </span>2006;<span class="ref-vol">24</span>(7):817\xe2\x80\x93819.</span> [<a href="/pubmed/16767078" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Biotechnology&amp;title=A+consensus+epitope+prediction+approach+identifies+the+breadth+of+murine+TCD8+-cell+responses+to+vaccinia+virus&amp;author=M+Moutaftsi&amp;author=B+Peters&amp;author=V+Pasquetto&amp;volume=24&amp;issue=7&amp;publication_year=2006&amp;pages=817-819&amp;pmid=16767078&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1940056&amp;issue-id=141968&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Journal of Biomedicine and Biotechnology</span> are provided here courtesy of <strong>Hindawi Limited</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1940056/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1940056/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1940056/pdf/JBB2007-90520.pdf">PDF (579K)</a></li> | <li><a href="#" data-citationid="PMC1940056" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1940056%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1940056%2F&amp;text=DNA%20Vaccines%20against%20Protozoan%20Parasites%3A%0AAdvances%20and%20Challenges"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1940056%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="17710244" data-aiid="1940056" data-aid="1940056" data-iid="141968" data-domainid="94" data-domain="jbb" data-accid="PMC1940056" data-md5="1143772939a5ad8561b501a9cbe95a1d"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:30:50-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1AD0C4E99ACEA10000000001DB01DA&amp;ncbi_session=8A1AD0C4E99AF891_0475SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1940056%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jbb&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1940056/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1AD0C4E99AF891_0475SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'